Page last updated: 2024-08-24

tenofovir and Hepatitis B

tenofovir has been researched along with Hepatitis B in 338 studies

Research

Studies (338)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	53 (15.68)	29.6817
2010's	191 (56.51)	24.3611
2020's	94 (27.81)	2.80

Authors

Authors	Studies
Aldern, KA; Almond, MR; Beadle, JR; De Clercq, E; Hostetler, KY; Korba, BE; Lampert, BM; Neyts, J; Painter, GR; Trost, LC	1
Fu, L; Gao, F; Huang, S; Zhang, L; Zhao, S; Zhen, Y; Zhou, X	1
Huang, X; Kallakury, BV; Kim, YW; Korolowicz, KE; Lee, KP; Li, B; Menne, S; Park, S; Suresh, M; Yon, C	1
Chuang, WL; Dai, CY; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Liang, PC; Nguyen, MH; Trinh, S; Yeh, ML; Yu, ML	1
An, H; Byun, KS; Jung, YK; Kim, JH; Kim, TH; Lee, YS; Seo, YS; Um, SH; Yeon, JE; Yim, HJ; Yim, SY	1
Ahn, SH; Chon, HY; Kim, SU; Kim, YJ; Lee, JH; Sinn, DH; Yoon, JH	1
Chen, WC; Cheng, JS; Kao, SS; Li, YD; Li, YR; Lin, HS; Lu, CM; Sun, WC; Tsai, TJ; Tsai, WL; Tsay, FW; Wang, HM; Yin, CH	1
Chen, L; Chen, X; Dai, E; Li, C; Li, S; Lv, X; Zhao, Z; Zhu, B	1
Chang, SY; Chen, GJ; Hsieh, SM; Huang, SH; Huang, YC; Hung, CC; Liu, WC; Liu, WD; Sheng, WH; Su, LH; Su, YC; Sun, HY	1
Chen, ZM; Cui, GL; Feng, YH; Huang, S; Li, GM; Li, GT; Li, J; Li, W; Li, WZ; Li, ZQ; Liang, HX; Lin, WB; Liu, N; Liu, YM; Lv, J; Pan, YJ; Song, N; Sun, CY; Wang, FS; Wang, M; Xu, GH; Xu, JH; Yu, ZJ; Zeng, QL; Zeng, YL; Zhang, DW; Zhang, GF; Zhang, GQ; Zhang, HX; Zhang, JY; Zhou, YH	1
De Clercq, E	4
Chang, IW; Chen, CY; Gaggar, A; Hsu, YC; Huang, YT; Lin, JT; Nguyen, MH; Pan, DZ; Podlaha, O; Suri, V; Tseng, CH; Wu, CY	1
Barday, Z; Geragotellis, A; Naicker, V; Patel, S; Sanglay, L; Sonderup, M; Spearman, CW; Wearne, N	1
Distenhreft, JIQ; Fioroti, CEA; Lacchine, K; Luchi, WM; Paulino, BB; Ramos, DR; Seguro, AC	1
Kamiya, K; Kishimoto, M; Komine, M; Kuwahara, A; Morimoto, N; Ohtsuki, M; Sugai, J	1
Anothaisintawee, T; Attia, J; Chaikledkaew, U; Chaiyakunapruk, N; McKay, GJ; Nguyen, HT; Phung, TL; Sobhonslidsuk, A; Talungchit, P; Thakkinstian, A; Thavorncharoensap, M	1
Bai, G; Chen, Z; Gao, F; Guo, F; Li, X; Wang, H; Wang, X; Yuan, Y	1
Barkema, HW; Coffin, CS; Samadi Kochaksaraei, G; Seow, CH; Shaheen, AA	1
Hill, A	1
Lampertico, P; Lim, YS	1
Afdhal, NH; Ankoma-Sey, V; Bae, H; Curry, MP; Dieterich, D; Frazier, L; Frick, A; Hann, HW; Kim, WR; Kwo, P; Milligan, S; Pan, CQ; Reddy, KR; Tong, MJ	1
Pan, CQ	2
Cottrell, M; Crane, H; Di Girolamo, J; Dumond, J; Gane, E; Kashuba, A; Kayes, T; Levy, MT; Lim, TH; Manandhar, S; Symonds, A	1
Arnouk, S; Dagher, NN; Feldman, DM; Papadopoulos, J; Park, JS; Stewart Lewis, Z; Whitsett, M	1
Caroupaye-Caroupin, L; Chhim, K; Chhun, S; Dim, B; Durier, C; Ear, E; Fernandez, L; Guillebaud, J; Hout, K; Kim, R; Ky, V; Laurent, D; Meyer, L; Nem, B; Nhoueng, S; Pech, S; Rekacewicz, C; Ros, B; Segeral, O; Sovann, S; Vong, C; Yay, C; Yin, S; Yom, S	1
Guo, XG; Huang, ZH; Liu, CW; Ou-Yang, S; Peng, TT; Yan, HZ; Yang, LL	1
Bao, Z; Dong, H; He, Y; Hong, X; Mo, R; Shen, S; Wang, G; Zhang, J; Zhang, Y	1
Chang, KC; Chang, MH; Chen, HL; Cheng, SW; Chiang, CL; Hsu, HY; Hu, JJ; Lai, MW; Lee, CN; Liu, CJ; Mu, SC; Ni, YH; Wen, WH; Wu, JF	1
Kumar, M	1
Gane, E; Kashuba, A; Levy, MT	1
Ran, R; Wang, M; Zhang, H; Zhu, Y	1
Boyd, A; Coffie, PA; Freedberg, KA; Hyle, EP; Kim, AY; Kouamé, MG; Larmarange, J; Mohareb, AM	1
Lim, TO; Lim, ZZ; Tan, AC; Teo, JS	1
Ahn, SH; Jung, CY; Kim, BS; Kim, HW; Kim, SU; Lee, HW; Lee, JI	1
Hsiao, NY; Hu, NC; Joseph Davey, D; Mashele, N; Mvududu, R; Myer, L; Sonderup, M; Wendy Spearman, C	1
Gartlehner, G; Harlfinger, J; Nußbaumer-Streit, B	1
Béguelin, C; Bernasconi, E; Boillat-Blanco, N; Calmy, A; Günthard, HF; Hofmann, E; Rauch, A; Schmid, P; Stöckle, M; Surial, B; Suter-Riniker, F; Wandeler, G	1
Adjei, G; Adu, F; Anyanful, A; Ephraim, RKD; Gavor-KWashi, C; Nsiah, P; Nyarko, SB; Thomford, NE	1
Afdhal, NH; Chan, HLY; Chen, CY; Coffin, CS; Elkhashab, M; Fung, SK; Greenbloom, S; Iyer, RP; Jackson, K; Jang, JW; Jeng, WJ; Kim, DJ; Kim, W; Kim, YJ; Lee, KS; Lim, YS; Liu, CJ; Locarnini, SA; Macfarlane, C; Ramji, A; Yuen, MF	1
Adekanle, O; Adeyemi, A; Anyabolu, C; Awowole, I; Ijadunola, M; Ijarotimi, O; Kuti, O; Makinde, O; Ndububa, D	1
Baum, MM; Kiser, JJ; Thomas, DL	1
Deng, Y; Pan, CQ; Park, J; Zhu, L	1
Barreiro, P; Corral, O; Mendoza, C; Moreno-Torres, V; Soriano, V	1
Hongfang, FU; Junli, Z; Xia, Z; Xiaoyu, HU; Ying, HE	1
Chan, KM; Cheng, CH; Chou, HS; Hung, HC; Lee, CF; Lee, JC; Lee, WC; Wang, YC; Wu, TH; Wu, TJ	1
Hwang, EG; Jung, EA; Kim, SG; Kim, YS; Yoo, JJ	1
Chuan, L; Linye, H; Tianfu, W; Xiaoyun, Z; Zhihui, L; Zijing, X	1
Cho, EJ; Jang, H; Kim, TM; Kim, YJ; Lee, HG; Lee, JH; Lee, YB; Yoon, JH; Yu, SJ	1
Janekrongtham, C; Jantarapakde, J; Lertpiriyasuwat, C; Pan-Ngum, W; Poovorawan, K; Punsuwan, N; Tangkijvanich, P; Thitichai, P	1
Cho, JY; Choi, D; Choi, Y; Hwang, S; Joo, DJ; Kang, KJ; Kim, BW; Kim, DG; Kim, DS; Kim, MS; Lee, JG; Nah, YW; Rhu, J; Ryu, JH; Yang, JD; You, YK	1
Althoff, KN; Cachay, ER; Carbonari, DM; Chew, K; Coburn, SB; Gebo, KA; Gill, MJ; Horberg, MA; Hull, M; Kim, HN; Kim, J; Kirk, GD; Kitahata, MM; Klein, MB; Lang, R; Lim, JK; Lo Re, V; Mayor, AM; McGinnis, KA; Moore, RD; Napravnik, S; Newcomb, CW; Reddy, KR; Seaberg, EC; Silverberg, MJ; Sterling, TR; Torgersen, J	1
Geng, H; Heng, H; Li, J; Liang, J; Liu, X; Zang, X	1
Abdullah, T; Aydin, O; Çolak, M; Kinaci, E; Ocak, İ; Özcan, FG; Özden, İ; Poturoğlu, Ş	1
Chandiwana, P; Duri, K; Gumbo, FZ; Marere, T; Mataramvura, H; Mazengera, LR; Mazhandu, AJ; Munjoma, PT	1
Liu, S; Liu, Z; Ma, X; Xin, Y; Zhao, Z	1
He, S; Wang, L; Wang, N; Zheng, Y	1
Duan, YQ; Hu, P	1
Li, C; Peng, W; Qi, W; Qi, X; Wen, T; Yi, M	1
Gao, S; Gui, X; Ke, H; Xiong, Y; Yang, R	1
Bhattacharya, D; Chihota, BV; Chilengi, R; Chung, RT; Egger, M; Mulenga, L; Vinikoor, MJ; Wandeler, G	1
Huang, YS; Hung, CC; Ko, WC; Lee, YC; Lee, YT; Li, CW; Lin, JJ; Lin, KY; Lin, SP; Liu, CE; Tang, HJ; Wang, NC; Yang, HJ	1
Bak, H; Byun, KS; Chang, SW; Hyun, MH; Jung, YK; Kim, JH; Kim, S; Lee, CU; Lee, HS; Lee, MJ; Lee, YS; Seo, YS; Um, SH; Yeon, JE; Yim, HJ	1
He, D; Jiang, H; Jin, J; Li, S; Lin, N; Ma, Z; Wang, Y; Zhou, H	1
Chen, K; Deng, H; Gao, H; Jiao, Q; Lei, Y; Li, H; Liang, S; Lin, L; Liu, H; Shi, Y; Xu, M; Zhuo, L	1
Chen, G; Cui, F; Liang, P; Liang, X; Wang, F; Yin, J; Zhuang, G	1
Pan, CQ; Wen, WH; Wong, GL	1
Acar, Ş; Çakmak, E; Eminler, AT; Fidan, S; Hülagü, S; İskender, G; Koksal, AS; Sezikli, M; Şirin, G; Toka, B; Üsküdar, O; Uslan, MI; Yildirim, AE	1
Chen, MB; Cui, WY; Wang, H; Xu, HL; Zheng, QH; Zheng, XW	1
Burger, DM; Dams, K; Francque, S; Jorens, PG; Vanwolleghem, T; Weyler, J	1
Amponsah-Dacosta, E; Blackard, JT; Burnett, RJ; Gededzha, MP; Kyaw, T; Lukhwareni, A; Mphahlele, MJ; Selabe, SG	1
Huang, J; Lin, S; Wang, M; Zhang, K; Zhu, Y	1
Chang, KC; Chang, MH; Chen, HL; Chiang, CL; Hsu, HY; Lai, MW; Lee, CN; Lin, LH; Mu, SC; Ni, YH; Wen, WH; Wu, JF; Zhao, LL	1
Cai, WP; Deng, XZ; Hu, FY; Lan, Y; Li, F; Li, LH; Nie, Y	1
Angkurawaranon, C; Bierhoff, M; Ehrhardt, S; McGready, R; Nosten, F; Pimanpanarak, M; Rijken, MJ; Thio, CL; van Vugt, M; Yotyingaphiram, W	1
Béguelin, C; Bernasconi, E; Boillat-Blanco, N; Chave, JP; Doco-Lecompte, T; Fehr, J; Furrer, H; Günthard, HF; Rauch, A; Schmid, P; Stöckle, M; Surial, B; Walti, LN; Wandeler, G	1
Angkurawaranon, C; Bierhoff, M; Carrara, V; Ehrhardt, S; Guo, N; Jia, Y; Jittamala, P; Ling, C; McGready, R; Nelson, KE; Nosten, F; Rijken, M; Thio, CL; Tongprasert, F; van Vugt, M; Watthanaworawit, W	1
Bukkems, VE; Burger, DM; Colbers, AP; Cressey, TR; Jourdain, G; Smolders, EJ	1
Chan, HLY; Gaggar, A; Ganova-Raeva, L; Khudyakov, Y; Kitrinos, K; Lara, J; Thai, H; Xia, GL; Xu, X	1
Baba, M; Furuya, K; Kawagishi, N; Kimura, M; Kitagataya, T; Maehara, O; Miyoshi, H; Morikawa, K; Nakai, M; Nakamura, A; Natsuizaka, M; Ogawa, K; Ohara, M; Ohnishi, S; Sakamoto, N; Shigesawa, T; Sho, T; Suda, G; Suzuki, K; Yamada, R; Yamamoto, K; Yamamoto, Y	1
Michler, T; Protzer, U; Velkov, S	1
Ostankova, YV; Semenov, AV; Serikova, EN; Totolian, AA; Zueva, EB	1
Shen, M; Sun, X; Wang, B; Wang, C; Xu, H; Yang, X; Zhu, K	1
Chen, ZM; Cui, GL; Ji, F; Li, GM; Li, J; Li, W; Li, ZQ; Liang, HX; Liu, YM; Lv, J; Pan, YJ; Sun, CY; Wang, FS; Xu, JH; Yu, ZJ; Zeng, QL; Zhang, DW; Zhang, GF	1
Bai, L; Chen, B; He, S; He, X; Hu, M; Liu, D; Liu, F; Luo, H; Luo, R; Ma, J; Song, X; Xie, Y; Yang, Y; Yao, D; Ye, T; Zhang, Z	1
Chan, HL	1
Enomoto, M; Kawada, N; Nishiguchi, S; Tamori, A; Yoshida, K	1
Angkurawaranon, C; Bierhoff, M; Devine, A; Kobphan, P; McGready, R; Nosten, FN; Rijken, MJ; Sriprawa, K; van Vugt, M	1
Cholongitas, E; Orfanidou, A; Papatheodoridis, GV	1
Chan, P; Cui, F; Fuzhen, W; Guomin, Z; Hallett, TB; Hui, Z; Nayagam, S; Ning, M; Thursz, M; Xiaojin, S; Zundong, Y	1
Byun, KS; Choi, J; Gwak, GY; Kim, JH; Kim, YJ; Kwon, SY; Lee, HC; Lee, YS; Lim, YS; Yoo, BC	1
Chang, SH	1
Bhat, R; Dash, R; Jayaram, B; Kiruthika, S; Rathore, AS; Vivekanandan, P	1
Barnes, E; Campbell, C; Collier, J; Cripps, S; Davies, J; Freeman, O; Jeffery, K; Matthews, PC; McNaughton, AL; Mokaya, J; Noble, T; Salih, H; Smith, DA; Várnai, KA; Wang, T; Woods, K	1
Busca Arenzana, C; Daroca, G; Martin-Carbonero, L; Mican, R; Perez-Valero, I; Vasquez, J	1
Khamadi, SA; Lihana, RW; Mabeya, SN; Ngugi, C; Nyamache, AK	1
Brouwer, WP	1
Brousseau, N; Gilca, V; Larouche, J; Mandal, S; Murphy, DG; Tedder, RS	1
Abdul Hafidz, MI; Lee, YY; Tan, SS	1
Gore, ML; Jatta, A; Lemoine, M; Ndow, G; Njie, R; Sabally, S; Sadiq, F; Shimakawa, Y; Sow, A; Suso, P; Tamba, S; Thursz, MR; Touré-Kane, C	1
Choi, HS; Jun, DW; Jung, TY; Lee, HL; Lee, KN; Lee, OY; Yoon, BC	1
Chen, JQ; Chen, JZ; Cheng, XY; Huang, FL; Huang, Z; Liao, ZW; Liu, JQ; Su, RK; Wang, WB	1
Abraham, I; Chacra, W; Danciu, OC; Kankanala, V; Remo, M	1
Lau, JSY; Ratnam, D; Woolley, I	1
Byun, KS; Hyun, MH; Kim, JH; Lee, YS; Yeon, JE	1
Ahir, BK; Li, LQ; Wu, GB; Zhang, CY; Zhong, JH	1
Akpomiemie, G; Arulappan, N; Chersich, MF; Majam, M; Mashabane, N; Moorhouse, M; Venter, WDF	1
Forde, KA; Kaplan, DE; Serper, M	1
Agarwal, A; Alexander, PE; Chang, Y; Foroutan, F; Guyatt, GH; Hepworth, E; Lee, Y; Lesi, O; Mah Ming, J; Merglen, A; Mir, H; Mirza, R; Siemieniuk, RA; Zeraatkar, D; Zhang, Y	1
Buti, M; Calleja, JL; Castillo, P; Esteban, R; García-Retortillo, M; Gómez Rubio, M; Gutiérrez, ML; López, J; Manzano, ML; Martín, L; Morano, LE; Morillas, RM; Prieto, M; Rodríguez, M; Simón, MA; Suárez, E; Yébenes, M; Zozaya, JM	1
Avihingsanon, A; Bloch, M; Cahn, P; East, L; Homony, B; Kaplan, R; Katlama, C; Leavitt, R; Molina, JM; Nguyen, BY; Rassool, M; Ratanasuwan, W; Rawlins, S; Rodgers, A; Rojas, E; Ruane, P; Sax, PE; Sklar, P; Squires, K; Teppler, H; Vandekerckhove, L; Wenning, L; Xu, X; Yazdanpanah, Y	1
Cathcart, AL; Delaney, WE; Kitrinos, KM; Liu, Y	1
Hendren, N; Hofmann, S; Moore, J; Rambally, S	1
Bhatia, R; Dash, D; Elavarasi, A; Tripathi, M	1
Burman, BE; Jhaveri, MA; Kowdley, KV	1
Endo, T; Ito, K; Saitoh, S; Sugiura, T; Suzuki, M; Tajiri, H; Tanaka, Y; Wakano, Y	1
Asriel, B; Chan, L; Eaton, EF; Wyatt, CM	1
Jhaveri, R; Meshnick, SR; Parr, JB; Wilson, P	1
Padma, UD; Surendran, S; Udayakumar, VP	1
Achalapong, J; Bowonwatanuwong, C; Buranabanjasatean, S; Chakhtoura, N; Chotivanich, N; Chung, RT; Cressey, TR; Decker, L; Harrison, L; Jourdain, G; Kanjanavikai, P; Khamduang, W; Klinbuayaem, V; Liampongsabuddhi, P; Limtrakul, A; Matanasarawut, W; Murphy, TV; Na Ayudhaya, OP; Nelson, NP; Ngo-Giang-Huong, N; Pol, S; Prommas, S; Puernngooluerm, P; Puthanakit, T; Putiyanun, C; Sabsanong, P; Salvadori, N; Sangsawang, S; Siberry, GK; Sirirungsi, W; Siriwachirachai, T; Suriyachai, P; Thanprasertsuk, S; Thongsawat, S; Tierney, C; Varadisai, S; Watts, DH; Yuthavisuthi, P	1
Becquet, V; Danel, C; Eholié, S; Larmarange, J; Masumbuko, JM; Nouaman, M; Plazy, M	1
Dickson, I	1
Abdou Chekaraou, M; Anglaret, X; Boyd, A; Danel, C; Delaugerre, C; Eholié, SP; Gabillard, D; Lacombe, K; Mahjoub, N; Maylin, S; Moh, R; Zoulim, F	1
Appiah, LT; Beloukas, A; Chadwick, D; Geretti, AM; Phillips, RO; Post, F; Ruggiero, A; Sarfo, FS; Smith, C; Stockdale, AJ; Villa, G	1
Agarwal, K; Bruce, M; Carey, I; Considine, A; Heaton, N; Heneghan, M; Lampertico, P; Lim, TY; Manini, MA; Passerini, M; Suddle, A; Whitehouse, G	1
Andersson, MI; Arends, JE; Glashoff, RH; Maponga, TG; Preiser, W; Taljaard, J; van Rensburg, CJ	1
Agarwal, K; Ahn, SH; Bae, H; Bhardwaj, N; Brunetto, M; Buti, M; Cathcart, AL; Çelen, MK; Chan, HLY; Chuang, WL; Flaherty, JF; Fung, S; Furusyo, N; Gaggar, A; Gane, EJ; Izumi, N; Janssen, HLA; Lau, AH; Lim, YS; Lin, L; Mani Subramanian, G; Marcellin, P; Pan, CQ; Seto, WK; Shalimar, D; Sharma, M; Suri, V; Trinh, H; Yoon, KT	1
Chan, P; Cui, F; Woodring, J; Xu, F	1
Akbulut, S; Harputluoglu, M; Yilmaz, S	1
Harrison, L; Jourdain, G; Ngo-Giang-Huong, N	1
Feld, JJ; Lok, ASF; Terrault, NA	1
Gerlich, W; Glebe, D	1
Cheung, KW; Ng, EHY; Seto, MTY	1
Alkım, C; Alkım, H; Colak, T; İyisoy, MS; Karayakar, F; Koksal, AR; Sahin, M; Şen, İ; Yetim, A	1
Alsunaid, SR; Ashraf, H; Soubani, AO	1
Jiang, XW; Li, LJ; Li, YT; Ye, JZ	1
Bulterys, M; Chen, L; Fan, B; Kourtis, AP; Liu, W; Shepard, C; Shepherd, JA; Wang, A; Wang, L; Wiener, J	1
Chao, Y; Hou, MC; Huang, YH; Lan, KH; Lee, IC; Li, CP; Lin, HC; Su, CW	1
Goyal, A; Romero-Severson, EO	1
Jiang, X; Luo, A; Ren, H	1
Chen, QY; Fang, ZL; Harrison, TJ; Hu, LP; Jia, HH; Li, KW; Liang, SJ; Ren, CC; Wang, C; Wang, XY; Yang, QL	1
Aslam, A; Ishtiaq, R; Lau, DTY	1
Chan, HLY	1
Naing, C; Poovorawan, Y; Tong, KS	1
Szeto, CC; Wong, GL; Wong, VW	1
Bian, Q; Chang, L; Li, R; Pan, CQ; Pang, Q; Tiongson, BC; Wang, M; Zhang, H; Zhu, Y	1
Andersson, M; Eilard, A; Lindh, M; Norkrans, G; Ringlander, J; Wejstål, R	1
Brancaccio, G; Fasano, M; Gaeta, GB; Grossi, A; Santantonio, TA	1
Jindal, A; Vyas, AK	1
Hassan, M; Lim, N; Singh, D	1
Duff, P; Sylvester-Armstrong, KR	1
Bulterys, M; Cressey, TR; Decker, L; Fan, B; Harrison, L; Jourdain, G; Khamduang, W; Kourtis, AP; Luvira, A; Ngo-Giang-Huong, N; Phanomcheong, S; Puangsombat, A; Putiyanun, C; Salvadori, N; Shepherd, JA; Siberry, GK; Srirompotong, U; Suwannarat, A; Teeyasoontranon, W; Tierney, C	1
Li, H; Zeng, J; Zheng, C	1
Atkinson, A; Bernasconi, E; Bonnet, F; Dabis, F; Dufour, JF; Fehr, J; Gjærde, LK; Kraus, D; Mauron, E; Neau, D; Peters, L; Rauch, A; Reiss, P; Rockstroh, J; Smit, C; van der Valk, M; Wandeler, G	1
Amanda, TO; Kpossou, AR; Séhonou, J; Sokpon, CNM; Vigan, J; Vignon, RK	1
Wahid, B	1
Andersson, M; Barnes, EJ; Burn, EAO; Goedhals, D; Matthews, PC; Mokaya, J; Pinedo-Villanueva, R; Tamandjou, CR	1
Abdool Karim, SS; Baxter, C; Blackard, JT; Ngcapu, S; Penton, PK; Powell, EA	1
Colmenero, J; Forns, X; Gómez-Hernando, M; Llach, J	1
Archampong, T; Bears, K; Chen, Y; Gong, Y; Kwara, A; Langaee, T; Lartey, M; Obo-Akwa, A; Ojewale, O; Sagoe, KW	1
Hu, X; Wang, L; Xu, F	1
Fan, LW; Ma, YL; Zhao, C	1
Pan, CQ; Zhang, H	1
Gatanaga, H; Hayashida, T; Oka, S; Tanuma, J	1
Brown, RS; Chang, MS; Emond, JC; Guarrera, JV; Heese, S; Olsen, SK; Pichardo, EM; Stiles, JB	1
Brown, RS; Brubaker, WD; Chang, MS; Emond, JC; Guarrera, JV; Olsen, SK; Pichardo, EM; Rosenthal-Cogan, L; Stiles, JB	1
Arberas-Díez, B; Casals-Seoane, F; García-Buey, L	1
Angeletti, C; Antonucci, G; Armignacco, O; Cassola, G; De Stefano, G; Girardi, E; Grossi, P; Mazzotta, F; Orani, A; Pagano, G; Petrosillo, N; Puoti, M; Sagnelli, C; Sagnelli, E	1
Abouljoud, MS; Bajjoka, IE; McGonigal, KH	1
Goyal, N; Gupta, S; Kumar, A; Taneja, S; Wadhawan, M	1
Feng, J; Hang, TJ; Jia, YY; Lu, CT; Song, Y; Sun, Y; Wang, S; Wen, AD; Yang, ZF; Zhao, JY	1
Bani-Sadr, F; de Vries-Sluijs, T; Dunn, D; Gilson, R; Jain, MK; Kuzushita, N; Mauss, S; Nüesch, R; Núñez, M; Peters, M; Pillay, D; Price, H; Reiberger, T; Stephan, C; Tan, L	1
Gulland, A	1
Botes, ME; Hamers, RL; Hoepelman, AI; Ive, P; Rinke de Wit, TF; Sigaloff, KC; Siwale, M; Stevens, WS; Wallis, CL; Zaaijer, HL	1
Kitrinos, KM; Liu, Y; Miller, MD	2
Calvaruso, V; Craxì, A	1
Ay, M; Ayaz, C; Barcin, T; Celen, MK; Dal, MS; Dal, T; Gulsun, S; Kalkanli, S; Kaya, S; Mert, D; Yildirim, N	1
Chung, RT; Fishman, JA; Wright, AJ	1
Amorosa, VK; Chang, KM; De La Torre, P; Frank, I; Gross, R; Hafkin, JS; Kostman, JR; Lo Re, V; Localio, AR; Mounzer, K; Osborn, MK; Stern, JJ	1
Becker, CB; Hamnvik, OP; Levy, BD; Loscalzo, J	1
Aberg, JA; Hollabaugh, K; Kang, M; Koletar, SL; Pham, V; Smurzynski, M; Wu, K	1
Coppola, N; Filippini, P; Martini, S; Pisaturo, M; Sagnelli, C; Sagnelli, E	1
Chatterjee, U; Davison, S; Glass, A; Greenup, AJ; Holdaway, S; Jackson, K; Levy, MT; Locarnini, SA; Nguyen, V; Samarasinghe, D; Tan, PK	1
Rao, W; Shen, Z; Xie, M	1
Bartholomew, ML; Chang, A; Tsai, N; Tsai, PJ; Yamada, S	1
Lampertico, P; Mangia, G; Viganò, M	1
Abe, M; Hiasa, Y; Hirooka, M; Ikeda, Y; Koizumi, Y; Kumagi, T; Matsuura, B; Ochi, H; Tada, F; Takada, K; Tokumoto, Y; Watanabe, T	1
Roche, B; Samuel, D	1
Adamidi, S; Alexopoulou, A; Deutsch, M; Koskinas, JS; Manolakopoulos, S; Pectasides, D; Skondra, M; Tampaki, M	1
James, G; Raza, M; Sidhu, P	1
Ehrhardt, S; Guo, N; Nelson, K; Thio, CL; Xie, C	1
Hamada-Tsutsumi, S; Imamura, J; Sugiura, W; Tanaka, Y; Watanabe, T; Yokomaku, Y	1
Furusyo, N; Hayashi, J; Hiramine, S; Mitsumoto, F; Murata, M; Ogawa, E; Shimizu, M; Takayama, K; Toyoda, K; Ura, K	1
Akarsu, M; Astarcıoğlu, İ; Hakim, GD; Karademir, S; Unek, T	1
Choudhary, NS; Goja, S; Menon, PB; Mohanka, R; Rastogi, A; Saigal, S; Saraf, N; Soin, AS	1
Chen, WD; Gong, GZ; Luo, Y; Zhou, HY	1
Alvey, N; Chan, EY; Cohen, E; Eswaran, S; Fayek, SA; Fleetwood, VA; Hertl, M; Shah, N; Singer, GA; Zielsdorf, S	1
Aktas, B; Aktürk, T; Basyigit, S; Nazligul, Y; Yılmaz, B	1
Ahmadinejad, Z; Dashti, H; Jafarian, A; Kasraianfard, A; Moini, M; Najafi, A; Nassiri-Toosi, M; Salimi, J	1
Fong, TL; Hsieh, MJ; Khemichian, S; Kim, J; Limurti, J; Zhang, SR	1
Ariaudo, A; Bonora, S; Calcagno, A; Carcieri, C; D'Avolio, A; De Nicolò, A; Di Perri, G; Sciandra, M; Simiele, M	1
Akıncı, H; Balık, İ; Başar, Ö; Çoban, Ş; Dökmeci, A; Güner, R; Kalkan, Ç; Örmeci, N; Özbaş, B; Özkan, H; Yalçı, A; Yüksel, İ; Yüksel, O	1
Boettiger, DC; Chaiwarith, R; Choi, JY; Ditangco, R; Durier, N; Kamarulzaman, A; Kantipong, P; Kerr, S; Kiertiburanakul, S; Kumarasamy, N; Law, M; Lee, CK; Li, PC; Merati, TP; Mustafa, M; Ng, OT; Oka, S; Pham, TT; Pujari, S; Ratanasuwan, W; Van Kinh, N; Vonthanak, S; Wong, WW; Yunihastuti, E; Zhang, F	1
Battegay, M; Bernasconi, E; Bihl, F; Calmy, A; Caminada, AP; Cavassini, M; Ledergeber, B; Martinetti, G; Rickenbach, M; Vernazza, P; Wandeler, G; Weber, R	1
Cao, F; Chen, T; He, Y; Jin, L; Liu, J; Qi, C; Wang, J; Yan, T; Yang, Y; Zhang, S; Zhao, Y	1
Aleman, J; de Fijter, CW; Franssen, EJ; van den Berk, GE	1
Abradelo, M; Calvo, J; Cambra, F; Castellano, G; Fernández, I; García, A; Hernández, O; Jiménez, C; Loinaz, C; Manrique, A; Manzano, M	1
Anglaret, X; Boyd, A; Danel, C; Delaugerre, C; Eholié, SP; Gabillard, D; Girard, PM; Lacombefor, K; Mahjoub, N; Maylin, S; Moh, R; Zoulim, F	1
Chu, CK; Konreddy, AK; Rawal, RK	1
Habib, G; Nashashibi, M	1
Castillo, E; Coffin, CS; Gao, S; Lee, SS; Martin, SR; Osiowy, C; Simmonds, K; van Marle, G; Virine, B; Wang, T	1
Almeida, JR; Esberard, EB; Lopes, PF; Lugon, JR; Medeiros, T; Mendes, GF; Patricio, JA; Silva, AA	1
Sonderup, MW; Spearman, CW; Suter, J	1
Aliosmanoglu, I; Cetinkaya, R; Erbis, H; Kocak, H; Suleymanlar, G; Ulger, BV; Yilmaz, VT	1
Du, S; Guo, F; Han, Y; Li, T; Li, Y; Lv, W; Qiu, Z; Song, X; Thio, CL; Wang, H; Wang, N; Xie, J; Zhu, T	1
Archampong, TN; Boamah, I; Flanigan, T; Gillani, FS; Kenu, E; Kwara, A; Lartey, M; Obo-Akwa, A; Sagoe, KW; Yang, H	1
Anderson, PL; Kiser, JJ; Lan, A; Naggie, S; Patel, K; Tillman, H; Wong, TC	1
Suzuki, Y	1
Chauhan, R; Kumar, M; Rooge, S; Sarin, SK; Singh, AK; Varshney, A	1
Benson, P; Brinson, C; Brunetta, J; Cheng, A; Crofoot, G; Das, M; Fordyce, M; Gallant, J; Garner, W; McCallister, S; Mills, A; Oka, S	1
Battegay, M; Bernasconi, E; Braun, DL; Darling, K; Günthard, HF; Hirzel, C; Hoffmann, M; Kouyos, RD; Kovari, H; Marzel, A; Rougemont, M; Scherrer, AU; Shilaih, M	1
Boyd, A; Delaugerre, C; Girard, PM; Lacombe, K; Lascoux-Combe, C; Lavocat, F; Maylin, S; Miailhes, P; Zoulim, F	1
Achalapong, J; Bowonwatanuwong, C; Chotivanich, N; Chung, RT; Cressey, TR; Decker, L; Harrison, L; Hongsiriwon, S; Hua, L; Jourdain, G; Khamduang, W; Klinbuayaem, V; Murphy, TV; Ngo-Giang-Huong, N; Pol, S; Puthanakit, T; Salvadori, N; Siberry, GK; Sirirungsi, W; Thongsawat, S; Tierney, C; Traisathit, P; Watts, DH	1
Mathew, JL	1
Gupta, B	1
Chawla, D	1
Antinori, S; Binda, F; Cattaneo, D; Cheli, S; Falvella, FS; Gervasoni, C; Mazzali, C; Milazzo, L; Ronzi, P; Sollima, S	1
Bénifla, JL; Berçot, B; Bergmann, JF; Chopin, D; Delcey, V; Evans, J; Lopes, A; Maylin, S; Sellier, PO; Simon, F; Simoneau, G	1
Dittmer, U; Esser, S; Jochum, C; Storim, J; Streeck, H; Timm, J; Verheyen, J	1
Aurpibul, L; Bunupuradah, T; Hansudewechakul, R; Kanjanavanit, S; Kosalaraksa, P; Lumbiganon, P; Puthanakit, T; Taeprasert, P	1
Chang, SC; Chang, SY; Chuang, YC; Huang, YS; Hung, CC; Lee, KY; Liu, WC; Sheng, WH; Su, YC; Sun, HY	1
Ahmed, KN; Hafeez, M; Khan, RG; Rafe, A; Rasool, G; Sarfraz, T	1
Arcaini, L; Gotti, M; Merli, M; Rattotti, S	1
Masoumy, EP; Stansfield, BK	1
Amanzada, A; Bremer, SCB; Eiffert, H; Ellenrieder, V; Neesse, A; Reinhardt, L; Ströbel, P; Wulf, G	1
Calabresi, A; Carosi, G; Cologni, G; Costarelli, S; Lapadula, G; Puoti, M; Quiros-Roldan, E; Tirelli, V; Torti, C; Zaltron, S	1
Amin, J; Avihingsanon, A; Bowden, S; Cooper, DA; Dore, GJ; Lewin, SR; Locarnini, S; Marks, P; Matthews, GV; Petcharapirat, P; Rerknimitr, R; Ruxrungtham, K; Sasadeusz, J	1
Boelle, PY; Bonnard, P; Boyd, A; Girard, PM; Gozlan, J; Lacombe, K; Lascoux-Combe, C; Miailhes, P; Molina, JM; Serfaty, L; Zoulim, F	1
Beckebaum, S; Cicinnati, VR; Gerken, G; Sotiropoulos, GC	1
Barreiro, P; García-Samaniego, J; Martín-Carbonero, L	1
Avihingsanon, A; Bowden, S; Dore, GJ; Lewin, SR; Locarnini, SA; Marks, P; Matthews, G; Perelson, AS; Ribeiro, RM; Ruxrungtham, K	1
Arrifin, N; Audsley, J; Ayres, A; Bartholomeusz, A; Crowe, SM; Lewin, SR; Locarnini, SA; Mijch, A; Sasadeusz, J; Yuen, LK	1
Alvarez-Uria, G; Ratcliffe, L; Vilar, J	1
Baumert, TF; Doffoel, M; Fafi-Kremer, S; Gut, JP; Habersetzer, F; Pastor, R; Schvoerer, E; Stoll-Keller, F	1
Amini-Bavil-Olyaee, S; Herbers, U; Luedde, T; Sheldon, J; Tacke, F; Trautwein, C	1
Barisani, T; Geusau, A; Jalili, A; Kinaciyan, T; Peck-Radosavljevic, M; Stingl, G; Wöhrl, S	1
Angus, PW; Patterson, SJ	1
Abdel Razek, W; Belghiti, J; Durand, F; Francoz, C; Lada, O; Marcellin, P; Moucari, R; Valla, D	1
Atkins, M; Fisher, M; Gilleece, Y; Grover, D; Mandalia, S; Murungi, A; Nelson, M; Tan, LK	1
de la Loma, GA; Mateos Lindemann, M; Moreira Vicente, V; Rodríguez Dominguez, M	1
Bourgeois, A; Calmy, A; Ciaffi, L; Delaporte, E; Ducos, J; Kouanfack, C; Koulla-Shiro, S; Laurent, C; Mougnutou, R; Mpoudi-Ngolé, E; Nkoué, N	1
Taéron, C	1
Abgueguen, P; Calès, P; Ducancelle, A; Gordien, E; Le Gal, F; Le Guillou-Guillemette, H; Lunel, F; Mansour, W; Pivert, A	1
Berg, T; Böcher, WO; Buggisch, P; de Man, RA; Deterding, K; Erhardt, A; Feucht, HH; Hüppe, D; Möller, B; Petersen, J; Reinders, JG; Rhode, P; Sarrazin, C; Spengler, U; Stein, K; Trojan, J; van Bömmel, F; Wasmuth, HE; Wedemeyer, H; Wiedenmann, B	1
Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I	1
Chee, GM; Poordad, F	1
Jiang, L; Yan, LN	1
Lok, AS	1
Coffin, CS; Michalak, TI; Mulrooney-Cousins, PM; Peters, MG; Roberts, JP; Terrault, NA; van Marle, G	1
Gianini, RJ; Gomes-Gouvêa, MS; Leite, OM; Locarnini, S; Martins, LG; Mendes-Correa, MC; Pinho, JR; Santana, RA; Silva, MH; Sitnik, R; Uip, DE; Yuen, L	1
de la Cruz-Lombardo, J; Jiménez-Pérez, M; Lozano-Rey, JM; Mongil Poce, L; Rodrigo-López, JM; Sáez-Gómez, AB	1
Brost, S; Eisenbach, C; Schnitzler, P; Stremmel, W	1
Christodoulou, DK; Katsanos, KH; Tsianos, EV; Tsianos, VE; Vagias, I; Zervou, E; Zioga, H; Zois, CD	1
Bartels, M; Berg, T; Hartmann, J; Jonas, S; Karlas, T; Maier, M; Mössner, J; Tillmann, HL; Weimann, A; Wiegand, J	1
Mallet, V; Pol, S; Vallet-Pichard, A	1
Andersen, ES; Christensen, PB; Frigstad, SO; Kjær, M; Konopski, Z; Krarup, H; Leutscher, P; Moessner, B; Weiland, O; Weis, N; Westin, J	1
Alterio, A; Comparcola, D; Corsetti, T; de Ville de Goyet, J; Diamanti, A; Iacono, A; Nobili, V; Pizzichemi, G; Sartorelli, MR; Torre, G	1
Akimoto, T; Hamano, Y; Iwazu, Y; Kusano, E; Miki, T; Muto, S; Numata, A; Otani, N; Saito, O; Sugase, T; Takemoto, F; Toshima, M; Ueda, Y	1
Antinori, S; Corbellino, M; Dodero, A; Foschi, A; Mazzocchi, A; Micheli, V; Milazzo, L; Montefusco, V; Zehender, G	1
Block, TM; Clearfield, E; Cuconati, A; Goddard, C; Guo, H; Mills, C; Morrey, JD; Motter, NE; Xiao, T; Xu, X; Yu, W; Zhao, K	1
Giles, M; Sasadeusz, J; Visvanathan, K	1
Holodniy, M; Schirmer, P; Winters, M	1
Branger, M; Collin, G; Fraqueiro, G; Gervais, A; Hamet, G; Lada, O; Marcellin, P; Martinot-Peignoux, M; Matheron, S; Moucari, R; Peytavin, G; Roquebert, B	1
Dalekos, GN; Tillmann, HL; Zachou, K	1
García-Alonso, FJ; Martín-Mateos, RM; Moreira Vicente, V	1
Boyd, A; Delaugerre, C; Girard, PM; Lacombe, K; Lavocat, F; Maylin, S; Simon, F; Zoulim, F	1
Fontana, RJ; Singal, AK	1
Cotterell, AH; Fisher, RA; Kimmel, M; Luketic, VA; Posner, MP; Puri, P; Sanyal, AJ; Shiffman, ML; Sterling, RK; Stravitz, RT	1
Bower, M; Kumar, N; Nelson, M	1
Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I; Ujhelyi, E	1
Ding, Y; Jia, Y; Liu, W; Lu, C; Song, Y; Sun, X; Wen, A; Yang, J	1
Akriviadis, E; Antoniadis, N; Cholongitas, E; Goulis, I; Papanikolaou, V; Vasiliadis, T	1
Kim, JH; Psevdos, G; Sharp, V	1
Hall, AM	1
Berg, T; Bock, FJ; Deterding, K; Feucht, HH; Hüppe, D; Möller, B; Trojan, J; van Bömmel, F; Wasmuth, HE; Wedemeyer, H	1
Babiker, ZOE; Hogan, C; Ustianowski, A; Wilkins, E	1
Arzumanyan, A; Bassit, L; Clayton, MM; Feitelson, MA; Kohler, JJ; Obikhod, A; Schinazi, RF; Sun, B	1
Grabmeier-Pfistershammer, K; Kosi, L; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Strassl, R	1
Gatanaga, H; Gomibuchi, H; Hosokawa, S; Kikuchi, Y; Kinai, E; Oka, S	1
Cholongitas, E; Papatheodoridis, GV	1
Angeli, P; Cavallin, M; Fasolato, S; Gatta, A; Gola, E; Morando, F; Rosi, S	1
Budeus, B; Cao, L; Chen, X; Hoffmann, D; Lu, M; Qin, B; Rayner, S; Wang, Y; Wu, C; Zhang, X	1
Agnaf, MR; Coyle, PV; Feeney, SA; Gerlich, WH; McCaughey, C; McDougall, N; Watt, AP; Wend, UC	1
Ingiliz, P; Ivanka, K; Krznaric, I; Martin, O; Obermeier, M; Patrick, I	1
Candusso, M; Iorio, R; Liccardo, D; Riva, S; Torre, G; Tufano, M	1
Berg, T; Schürmann, D; van Bömmel, F; Wünsche, T	1
Dieterich, DT	1
Fung, HB; Piacenti, FJ; Stone, EA	1
Benhamou, Y; Thibault, V; Tubiana, R	1
Berg, T; Hopf, U; Schernick, A; Van Bömmel, F	1
Vere Hodge, A	1
Buster, EH; Schalm, SW; van der Eijk, AA	1
Benhamou, Y	1
Benhamou, Y; Cahour, A; Katlama, C; Lada, O; Poynard, T; Thibault, V	1
Bani-Sadr, F; Molina, JM; Palmer, P; Scieux, C	1
Duncan, R; Lau, DT; Madariaga, JR; Montalbano, M; Muslu, H; Neff, GW; Nery, C; Nery, J; O'Brien, CB; Ruiz, P; Safdar, K; Schiff, ER; Shire, NJ; Tzakis, AG	1
Däumer, M; Kaiser, R; Matz, B; Rockstroh, JK; Schewe, CK; Schildgen, O; Vogel, M; Weitner, L	1
Cañas, C; Casais, LA; Casanova, A; Chahri, N; Figueras, J; Gornals, J; Lopez, C; Taltavull, TC; Verdura, B	1
Berg, T; van Bömmel, F	1
Buti, M; Esteban, R	1
Bartholomeusz, A; Camino, N; Klausen, G; Kuiper, M; Locarnini, S; Lutz, T; Mauss, S; Núñez, M; Rodés, B; Sheldon, J; Soriano, V; Tacke, F	1
de Man, RA; de Vries-Sluijs, TE; Hansen, BE; Osterhaus, AD; van der Eijk, AA; van der Ende, ME	1
Benhamou, Y; Fleury, H; Katlama, C; Le Teuff, G; Pellegrin, I; Piketty, C; Rozenbaum, W; Trimoulet, P; Trylesinski, A; Urbinelli, R	1
Schiff, ER; Schreibman, IR	1
Gallant, JE; Pham, PA	1
Lok, AS; Wong, SN	1
Berg, T; Feucht, HH; Hüppe, D; Möller, B; Sarrazin, C; Spengler, U; van Bömmel, F; Wiedenmann, B; Zöllner, B	1
Grant, RM; Levy, V	1
Alloui, C; Bouhassoune, K; Calboreanu, A; Dény, P; Gordien, E; Legal, F; Podevin, P; Rico-Garcia, M; Salmon-Céron, D; Sogni, P	1
Hester, J; Jain, MK; Lee, WM; Parekh, NK	1
Attar, N; Comanor, L; Elkin, C; Jain, MK; Keiser, P; Kipnis, P; Lee, WM; Leung, K; Ocampo, A; White, C	1
Lok, AS; Tan, J	1
Rimland, D; Rouphael, NG; Talati, NJ	1
Dore, GJ; Matthews, GV	1
Cooper, DA; Dore, GJ; Matthews, GV	1
Colombo, S; Del Poggio, P; Jamoletti, C; Oggionni, M; Puhalo, V; Zaccanelli, M	1
Ayliffe, U; Dervisevic, S; Garcia-Diaz, A; Geretti, AM; Gilson, R; Johnson, M; Nebbia, G; Smith, C; Tedder, R	1
Clayton, MM; Feitelson, MA; Schinazi, RF; Sun, B	1
Janssen, HL; Reijnders, JG	1
Degertekin, B; Husain, M; Lok, AS; Oberhelman, K; Tan, J; Wong, SN	1

Reviews

56 review(s) available for tenofovir and Hepatitis B

Article	Year
Tribute to John C. Martin at the Twentieth Anniversary of the Breakthrough of Tenofovir in the Treatment of HIV Infections. Viruses, 2021, 12-02, Volume: 13, Issue:12 Topics: Alanine; Anti-HIV Agents; Drug Therapy, Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Hepatitis B; History, 20th Century; History, 21st Century; HIV; HIV Infections; Humans; Pre-Exposure Prophylaxis; Reverse Transcriptase Inhibitors; Tenofovir	2021
Tenofovir-induced renal and bone toxicity: report of two cases and literature review. Revista do Instituto de Medicina Tropical de Sao Paulo, 2022, Volume: 64 Topics: Anti-HIV Agents; Female; Hepatitis B; HIV Infections; Humans; Kidney; Kidney Diseases; Middle Aged; Tenofovir	2022
Comparative efficacy and safety of pharmacologic interventions to prevent mother-to-child transmission of hepatitis B virus: a systematic review and network meta-analysis. American journal of obstetrics and gynecology, 2022, Volume: 227, Issue:2 Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Infant; Infectious Disease Transmission, Vertical; Network Meta-Analysis; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load	2022
Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission-A review of maternal and infant outcomes. Liver international : official journal of the International Association for the Study of the Liver, 2022, Volume: 42, Issue:8 Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load	2022
Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B. The lancet. HIV, 2022, Volume: 9, Issue:8 Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Pre-Exposure Prophylaxis; Risk Assessment; Tenofovir	2022
The Use of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide for Preventing Vertical Transmission of Hepatitis B. Journal of clinical gastroenterology, 2023, 02-01, Volume: 57, Issue:2 Topics: Adenine; Antiviral Agents; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Infant; Infectious Disease Transmission, Vertical; Tenofovir	2023
Fuzheng Huayu preparation (/) combined with tenofovir disoproxil fumarate on hepatitis B: a systematic review and Meta-analysis. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2023, Volume: 43, Issue:2 Topics: Albumins; Antiviral Agents; Collagen Type III; Hepatitis B; Humans; Liver Cirrhosis; Tenofovir; Treatment Outcome	2023
Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis. Hepatology international, 2023, Volume: 17, Issue:4 Topics: Adenine; Alanine; Cholesterol; Cholesterol, LDL; Dyslipidemias; Hepatitis B; Hepatitis B, Chronic; Humans; Tenofovir; Triglycerides	2023
Fanconi syndrome induced by the long-term use of tenofovir disoproxil fumarate: a case report and literature review. The Journal of international medical research, 2023, Volume: 51, Issue:8 Topics: Fanconi Syndrome; Female; Hepatitis B; Humans; Pain; Tenofovir; Tomography, X-Ray Computed	2023
Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis. BMC gastroenterology, 2023, Nov-10, Volume: 23, Issue:1 Topics: Adenine; Alanine; Antiviral Agents; Bone and Bones; Creatinine; Fumarates; Hepatitis B; Hepatitis B, Chronic; Humans; Kidney; Network Meta-Analysis; Tenofovir; Treatment Outcome	2023
Efficacy and safety of tenofovir disoproxil fumarate versus entecavir in the treatment of acute-on-chronic liver failure with hepatitis B: a systematic review and meta-analysis. BMC gastroenterology, 2023, Nov-13, Volume: 23, Issue:1 Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; End Stage Liver Disease; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Prospective Studies; Retrospective Studies; Severity of Illness Index; Tenofovir; Treatment Outcome	2023
[Research progress on the effect of tenofovir disoproxil fumarate on blood lipid profile]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023, Oct-20, Volume: 31, Issue:10 Topics: Adenine; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lipids; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome	2023
Role of tenofovir disoproxil fumarate in prevention of perinatal transmission of hepatitis B virus from mother to child: a systematic review and meta-analysis. The Korean journal of internal medicine, 2021, Volume: 36, Issue:1 Topics: Antiviral Agents; Child; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome; Viral Load	2021
Hepatitis B-management of acute infection and active inflammation in pregnancy-a hepatologist's perspective. Best practice & research. Clinical obstetrics & gynaecology, 2020, Volume: 68 Topics: Adult; Antiviral Agents; Child; DNA, Viral; Female; Gastroenterologists; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Inflammation; Male; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Tenofovir	2020
Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy. International journal of molecular sciences, 2021, Feb-01, Volume: 22, Issue:3 Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Genotype; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Randomized Controlled Trials as Topic; Reproducibility of Results; Tenofovir; Treatment Outcome; Viral Load	2021
Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts. Liver international : official journal of the International Association for the Study of the Liver, 2021, Volume: 41, Issue:7 Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Liver Transplantation; Recurrence; Tenofovir; Treatment Outcome	2021
Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load. Scientific reports, 2017, 06-23, Volume: 7, Issue:1 Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Odds Ratio; Outcome Assessment, Health Care; Pregnancy; Publication Bias; Tenofovir; Viral Load	2017
Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis. BMJ open, 2017, Sep-11, Volume: 7, Issue:9 Topics: Adult; Anti-Retroviral Agents; Drug Combinations; Emtricitabine; Female; Hepatitis B; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Ritonavir; Tenofovir; Young Adult; Zidovudine	2017
Role of tenofovir alafenamide (TAF) in the treatment and prophylaxis of HIV and HBV infections. Biochemical pharmacology, 2018, Volume: 153 Topics: Adenine; Alanine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Pre-Exposure Prophylaxis; Tenofovir; Treatment Outcome	2018
Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug. Current opinion in nephrology and hypertension, 2018, Volume: 27, Issue:2 Topics: Adenine; Alanine; Antiviral Agents; Bone Density; Drug Interactions; Glomerular Filtration Rate; Hepatitis B; HIV Infections; Humans; Kidney Diseases; Pre-Exposure Prophylaxis; Prodrugs; Tenofovir	2018
Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis. World journal of gastroenterology, 2018, Jul-28, Volume: 24, Issue:28 Topics: Antibiotic Prophylaxis; Antiviral Agents; Coinfection; Disease Progression; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Incidence; Interferons; Recurrence; Tenofovir; Treatment Outcome; Virus Activation	2018
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis. Virology journal, 2018, 09-10, Volume: 15, Issue:1 Topics: Alanine Transaminase; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Lamivudine; RNA, Viral; Tenofovir; Treatment Outcome	2018
Okuda lecture: Challenges of hepatitis B in the era of antiviral therapy. Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:3 Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Guanine; Hepatitis B; Hepatitis B e Antigens; Humans; Immune Tolerance; Liver Neoplasms; Nucleotides; Tenofovir; Withholding Treatment	2019
Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis. BMC infectious diseases, 2018, Nov-14, Volume: 18, Issue:1 Topics: Adenine; Adult; Aged; Antiviral Agents; Coinfection; Emtricitabine; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Network Meta-Analysis; Organophosphonates; Tenofovir; Treatment Outcome; Young Adult	2018
Evidence for Use of Tenofovir in Pregnancy to Prevent Perinatal Transmission of Hepatitis B Infection. Clinical obstetrics and gynecology, 2019, Volume: 62, Issue:4 Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viremia	2019
Guides concerning tenofovir exposure via breastfeeding: A comparison of drug dosages by developmental stage. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019, Volume: 87 Topics: Animals; Anti-HIV Agents; Antiviral Agents; Female; Hepatitis B; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Male; Milk, Human; Pregnancy; Pregnancy Complications, Infectious; Tenofovir	2019
Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis. PloS one, 2013, Volume: 8, Issue:7 Topics: Adenine; Anti-HIV Agents; Coinfection; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Organophosphonates; Tenofovir	2013
Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible? Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34 Suppl 1 Topics: Adenine; Administration, Oral; Antiviral Agents; Carcinoma, Hepatocellular; Fibrosis; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Telbivudine; Tenofovir; Thymidine	2014
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:10 Topics: Adenine; Antiviral Agents; Coinfection; DNA, Viral; Drug Therapy, Combination; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Organophosphonates; Ribavirin; RNA, Viral; Tenofovir; Virus Replication	2014
Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy. Expert opinion on biological therapy, 2014, Volume: 14, Issue:7 Topics: Adenine; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Carrier State; Disease Management; DNA, Viral; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Organophosphonates; Rituximab; Tenofovir; Virus Activation	2014
Prevention of hepatitis B virus reinfection in liver transplant recipients. Intervirology, 2014, Volume: 57, Issue:3-4 Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Liver; Liver Cirrhosis; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Transplant Recipients; Virus Replication	2014
Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Jan-15, Volume: 60, Issue:2 Topics: Adenine; Anti-HIV Agents; Breast Feeding; Disease Transmission, Infectious; Female; Hepatitis B; Humans; Infant, Newborn; Lamivudine; Organophosphonates; Pregnancy; Tenofovir	2015
Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: A systematic review and meta-regression analysis. Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Combined Modality Therapy; Databases, Bibliographic; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Liver Neoplasms; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Prognosis; Regression Analysis; Tenofovir	2015
Tenofovir alafenamide (Vemlidy) for hepatitis B. The Medical letter on drugs and therapeutics, 2017, Jan-02, Volume: 59, Issue:1511 Topics: Adenine; Alanine; Animals; Antiviral Agents; Clinical Trials as Topic; Hepatitis B; Humans; Tenofovir	2017
Antiviral therapies for managing viral hepatitis in lymphoma patients. Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:4 Topics: Antiviral Agents; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis C; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Rituximab; Tenofovir; Virus Activation	2017
Hepatitis B and liver transplantation: 2008 update. Reviews in medical virology, 2009, Volume: 19, Issue:1 Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B Vaccines; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine	2009
[Hepatitis B in patients with HIV infection]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 7 Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Comorbidity; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; HIV; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Virus Replication	2008
Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues. Current opinion in organ transplantation, 2009, Volume: 14, Issue:3 Topics: Adenine; Administration, Oral; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Graft Survival; Guanine; Hepatitis B; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Nucleosides; Nucleotides; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome	2009
Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation. World journal of gastroenterology, 2010, May-28, Volume: 16, Issue:20 Topics: Adenine; Antiviral Agents; Asia; Guanine; Hepatitis B; Hepatitis B virus; Humans; Interferons; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir	2010
Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature. Journal of Crohn's & colitis, 2010, Volume: 4, Issue:4 Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Greece; Hepatitis B; Hepatitis C; Humans; Inflammatory Bowel Diseases; Interferon-alpha; Lamivudine; Male; Middle Aged; Organophosphonates; Prevalence; Retrospective Studies; Ribavirin; Tenofovir; Treatment Outcome	2010
The impact of human immunodeficiency virus on viral hepatitis. Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31 Suppl 1 Topics: Adenine; Antiviral Agents; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis C; Hepatitis Viruses; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine	2011
The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond. Biochemical pharmacology, 2011, Jul-15, Volume: 82, Issue:2 Topics: Adenine; Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; Guanosine; Hepatitis B; HIV Infections; Humans; Organophosphonates; Prodrugs; Structure-Activity Relationship; Tenofovir	2011
Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding. Antiviral therapy, 2011, Volume: 16, Issue:5 Topics: Adenine; Antiviral Agents; Breast Feeding; Female; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Telbivudine; Tenofovir; Thymidine	2011
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat? Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:4 Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Interferons; Lamivudine; Liver Failure, Acute; Organophosphonates; Tenofovir	2012
[Pharmacological treatment of acute hepatitis B]. Medicina clinica, 2012, May-19, Volume: 138, Issue:14 Topics: Acute Disease; Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Lamivudine; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Spain; Telbivudine; Tenofovir; Thymidine; Treatment Outcome	2012
Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis. Alimentary pharmacology & therapeutics, 2012, Volume: 35, Issue:6 Topics: Adenine; Administration, Oral; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Pyrimidinones; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Time Factors; Treatment Outcome; Viral Load	2012
Update on tenofovir toxicity in the kidney. Pediatric nephrology (Berlin, Germany), 2013, Volume: 28, Issue:7 Topics: Adenine; Animals; Anti-HIV Agents; Antiviral Agents; Hepatitis B; HIV Infections; Humans; Kidney; Kidney Diseases; Organophosphonates; Risk Factors; Tenofovir	2013
High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013, Volume: 13, Issue:2 Topics: Adenine; Antiviral Agents; DNA, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Liver Failure; Liver Transplantation; Nucleotides; Organophosphonates; Recurrence; Tenofovir; Time Factors; Treatment Outcome	2013
Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection. Clinical therapeutics, 2002, Volume: 24, Issue:10 Topics: Adenine; Animals; Anti-HIV Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Hepatitis B; HIV Infections; HIV-1; Humans; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir	2002
Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions. Antiviral research, 2003, Volume: 60, Issue:2 Topics: Adenine; Antiviral Agents; DNA, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infectious Disease Transmission, Professional-to-Patient; Interferon-alpha; Lamivudine; Organophosphonates; Organophosphorus Compounds; Physicians; Risk Factors; Risk Management; Tenofovir; Viral Load	2003
Drugs in development for hepatitis B. Drugs, 2005, Volume: 65, Issue:11 Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Deoxycytidine; Emtricitabine; Guanine; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Nucleosides; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir	2005
Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues. Annals of clinical microbiology and antimicrobials, 2006, Apr-06, Volume: 5 Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Nucleotides; Organophosphonates; Recurrence; Tenofovir	2006
Tenofovir disoproxil fumarate for the treatment of HIV infection. Expert opinion on drug metabolism & toxicology, 2006, Volume: 2, Issue:3 Topics: Adenine; Animals; Drug Administration Schedule; Drug Interactions; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Organophosphonates; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tenofovir	2006
Tenofovir disoproxil fumarate: role in hepatitis B treatment. Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:2 Topics: Adenine; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Organophosphonates; Tenofovir; Treatment Outcome	2006
Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-01, Volume: 43, Issue:7 Topics: Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Deoxycytidine; Drug Combinations; Emtricitabine; Guanine; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Organophosphonates; Preventive Medicine; Tenofovir	2006
Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature. AIDS (London, England), 2007, Mar-30, Volume: 21, Issue:6 Topics: Adenine; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; HIV Seropositivity; Humans; Lamivudine; Middle Aged; Organophosphonates; Tenofovir	2007

Trials

34 trial(s) available for tenofovir and Hepatitis B

Article	Year
Randomized Controlled Study of Tenofovir versus Lamivudine Followed by Tenofovir in Severe Exacerbation of Hepatitis B. Antimicrobial agents and chemotherapy, 2022, 02-15, Volume: 66, Issue:2 Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Tenofovir; Treatment Outcome	2022
Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation. Gastroenterology, 2022, Volume: 162, Issue:4 Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; RNA; Tenofovir; Treatment Outcome; Viral Load; Viremia; Virus Integration; Virus Replication	2022
Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial. The Lancet. Infectious diseases, 2022, Volume: 22, Issue:8 Topics: Alanine Transaminase; Antiviral Agents; Cambodia; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Tenofovir; Viral Load	2022
Characterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infants. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3 Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viremia	2023
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver, 2023, Volume: 43, Issue:1 Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; RNA; Tenofovir; Treatment Outcome	2023
Tenofovir versus entecavir on the prognosis of hepatitis B-related hepatocellular carcinoma after surgical resection: a randomised controlled trial. International journal of surgery (London, England), 2023, Oct-01, Volume: 109, Issue:10 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B, Chronic; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Prognosis; Tenofovir; Treatment Outcome	2023
Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study. Journal of Korean medical science, 2023, Jul-17, Volume: 38, Issue:28 Topics: Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Prospective Studies; Rituximab; Symptom Flare Up; Tenofovir	2023
The effect of switch therapy to tenofovir versus entecavir maintenance on recurrence of hepatocellular carcinoma after surgery (SWITE): study protocol for a randomized controlled trial. Trials, 2023, Dec-02, Volume: 24, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Tenofovir; Treatment Outcome	2023
Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2022, Volume: 20, Issue:2 Topics: Alanine; Antiviral Agents; Hepatitis B; Hepatitis B, Chronic; Humans; Tenofovir; Treatment Outcome	2022
Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial. BMC public health, 2017, Jul-04, Volume: 17, Issue:Suppl 3 Topics: Adult; Albuminuria; Anemia; Anti-HIV Agents; Antigens; CD4 Lymphocyte Count; Cities; Clinical Laboratory Techniques; Coinfection; Cost-Benefit Analysis; Creatinine; Female; Health Care Costs; Hemoglobins; Hepatitis B; HIV Infections; Humans; Kidney Diseases; Male; Mass Screening; Neutropenia; South Africa; Tenofovir; Transaminases	2017
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study. PloS one, 2017, Volume: 12, Issue:9 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Leukemia; Male; Middle Aged; Post-Exposure Prophylaxis; Rituximab; Serologic Tests; Tenofovir	2017
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. The lancet. HIV, 2017, Volume: 4, Issue:11 Topics: Administration, Oral; Adult; Anti-HIV Agents; Biological Availability; Coinfection; Double-Blind Method; Emtricitabine; Female; Hepatitis B; Hepatitis C; HIV Infections; HIV-1; Humans; Male; Quality of Life; Raltegravir Potassium; RNA, Viral; Tenofovir; Viral Load	2017
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B. The New England journal of medicine, 2018, Mar-08, Volume: 378, Issue:10 Topics: Adolescent; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Young Adult	2018
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. Journal of hepatology, 2018, Volume: 68, Issue:4 Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Alanine Transaminase; Bone Density; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Female; Glomerular Filtration Rate; Hepatitis B; Hepatitis B e Antigens; Humans; Male; Middle Aged; Tenofovir; Young Adult	2018
Tenofovir Disoproxil Fumarate Use during Pregnancy and Infant Bone Health: the Tenofovir in Pregnancy Pilot Study. The Pediatric infectious disease journal, 2018, Volume: 37, Issue:11 Topics: Adult; Anti-HIV Agents; Bone and Bones; Bone Density; China; Coinfection; Female; Hepatitis B; HIV Infections; Humans; Infant; Infant Health; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Young Adult	2018
Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 06-18, Volume: 69, Issue:1 Topics: Adult; Antiviral Agents; Bone Density; Double-Blind Method; Female; Gestational Age; Hepatitis B; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Young Adult	2019
Impact on L-carnitine Homeostasis of Short-term Treatment with the Pivalate Prodrug Tenofovir Dipivoxil. Basic & clinical pharmacology & toxicology, 2013, Volume: 113, Issue:6 Topics: Adenine; Adult; Antiviral Agents; Carnitine; Dose-Response Relationship, Drug; Female; Hepatitis B; Herpes Simplex; Homeostasis; Humans; Male; Organophosphonates; Prodrugs; Tenofovir	2013
Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women. Digestive diseases and sciences, 2014, Volume: 59, Issue:11 Topics: Adenine; Adolescent; Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Odds Ratio; Organophosphonates; Pregnancy; Risk Factors; Tenofovir; Viremia; Young Adult	2014
Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:5 Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Female; Follow-Up Studies; Guanine; Hepatitis B; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome; Young Adult	2015
Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients. BMC infectious diseases, 2016, Jan-13, Volume: 16 Topics: Adolescent; Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Cross-Sectional Studies; Female; Ghana; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Tenofovir; Viral Load; Viremia; Young Adult	2016
Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected Adults. Journal of acquired immune deficiency syndromes (1999), 2016, 11-01, Volume: 73, Issue:3 Topics: Adenine; Alanine; Anti-HIV Agents; Cobicistat; Coinfection; Drug Combinations; Drug Substitution; Emtricitabine; Female; Hepatitis B; HIV Infections; Humans; Male; Middle Aged; Quinolones; Tenofovir; Treatment Outcome	2016
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus BMC infectious diseases, 2016, 08-09, Volume: 16 Topics: Adult; Alanine Transaminase; Antibiotic Prophylaxis; Antiviral Agents; Biomarkers; Double-Blind Method; Female; Gestational Age; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Immunoglobulins; Infant; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Thailand; Viral Load	2016
Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women. European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:3 Topics: Antiviral Agents; Biomarkers; Child, Preschool; DNA, Viral; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Paris; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Tenofovir; Time Factors; Treatment Outcome; Viral Load; Viremia	2017
Breakthrough in the prevention of mother-to-child hepatitis B transmission? Journal of perinatology : official journal of the California Perinatal Association, 2017, Volume: 37, Issue:4 Topics: Adult; Antiviral Agents; Congenital Abnormalities; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Young Adult	2017
Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV. Antiviral therapy, 2008, Volume: 13, Issue:3 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tenofovir; Time Factors; Treatment Outcome; Virus Replication	2008
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:4 Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Tenofovir; Thailand; Treatment Outcome; Zidovudine	2008
Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients. Antiviral therapy, 2008, Volume: 13, Issue:5 Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Proportional Hazards Models; Tenofovir; Treatment Outcome; Viral Load	2008
Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy. Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:4 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biopsy; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Lamivudine; Liver; Male; Middle Aged; Models, Biological; Organophosphonates; Prospective Studies; Tenofovir; Viral Load; Young Adult	2009
Relative bioavailability study of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy male fasted volunteers. Clinical drug investigation, 2012, May-01, Volume: 32, Issue:5 Topics: Adenine; Administration, Oral; Adolescent; Adult; Area Under Curve; Biological Availability; Cross-Over Studies; Hepatitis B; Humans; Male; Middle Aged; Organophosphonates; Phosphorous Acids; Prodrugs; Reverse Transcriptase Inhibitors; Tenofovir; Therapeutic Equivalency; Young Adult	2012
Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Oct-01, Volume: 39, Issue:7 Topics: Adenine; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir	2004
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. Antiviral therapy, 2005, Volume: 10, Issue:6 Topics: Adenine; Adult; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Models, Molecular; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Selection, Genetic; Tenofovir	2005
Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response. Journal of viral hepatitis, 2007, Volume: 14, Issue:3 Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Viral Load	2007
Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B. World journal of gastroenterology, 2007, Aug-14, Volume: 13, Issue:30 Topics: Adenine; Adult; Aged; Antiviral Agents; Dose-Response Relationship, Drug; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Male; Middle Aged; Organophosphonates; Tenofovir; Viremia	2007
Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. Journal of hepatology, 2008, Volume: 48, Issue:3 Topics: Adenine; Adult; Aged; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Male; Middle Aged; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Viral Load	2008

Other Studies

248 other study(ies) available for tenofovir and Hepatitis B

Article	Year
Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10 Topics: Adenine; Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Female; Hepatitis B; Hepatitis B virus; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Magnetic Resonance Spectroscopy; Male; Organophosphonates; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Tenofovir	2007
Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells. Bioorganic & medicinal chemistry letters, 2019, 10-01, Volume: 29, Issue:19 Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Benzamides; Drug Design; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Molecular Docking Simulation; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization	2019
Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks. Cells, 2021, 09-05, Volume: 10, Issue:9 Topics: Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Disease Models, Animal; Drug Therapy, Combination; Endocytosis; Hep G2 Cells; Hepatitis B; Hepatitis B Virus, Woodchuck; Host-Pathogen Interactions; Humans; Liver; Marmota; Tenofovir; Vimentin; Viral Load; Virus Internalization; Virus Replication	2021
Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide Journal of the Formosan Medical Association = Taiwan yi zhi, 2022, Volume: 121, Issue:7 Topics: Adenine; Alanine; Body Weight; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Male; Middle Aged; Retrospective Studies; Tenofovir	2022
Determinants of re-compensation in patients with hepatitis B virus-related decompensated cirrhosis starting antiviral therapy. Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:1 Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Tenofovir; Treatment Outcome	2022
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients. Hepatology international, 2021, Volume: 15, Issue:6 Topics: Aged; Alanine; Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Tenofovir; Treatment Outcome	2021
Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus. Medicine, 2021, Nov-05, Volume: 100, Issue:44 Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Viral Load	2021
Evolution of Hepatitis B Virus (HBV) Serologic Markers Among Antiretroviral-Naive Young People Living With Human Immunodeficiency Virus Who Had Undergone Neonatal HBV Vaccination and Initiated Antiretroviral Therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 09-14, Volume: 75, Issue:5 Topics: Adolescent; Adult; Anti-Retroviral Agents; DNA-Directed RNA Polymerases; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Herpesvirus 1, Cercopithecine; HIV; HIV Infections; Humans; Infant, Newborn; Retrospective Studies; Tenofovir; Vaccination; Young Adult	2022
Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective Study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2022, Volume: 20, Issue:12 Topics: Adenine; Adult; Antiviral Agents; China; Cleft Lip; Cleft Palate; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Infant, Newborn; Pregnancy; Pregnant Women; Prospective Studies; Tenofovir	2022
Tenofovir alafenamide: An initial experience at Groote Schuur Hospital, Cape Town, South Africa. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2022, Feb-01, Volume: 112, Issue:2 Topics: Adult; Alanine; Antiviral Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; South Africa; Tenofovir; Treatment Outcome; Viral Load	2022
Case of psoriasis with hepatitis B virus infection during tumor necrosis factor inhibitor treatment successfully treated with ixekizumab and tenofovir alafenamide fumarate. The Journal of dermatology, 2022, Volume: 49, Issue:6 Topics: Adenine; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Fumarates; Hepatitis B; Hepatitis B virus; Humans; Psoriasis; Tenofovir; Tumor Necrosis Factor Inhibitors	2022
Downregulation of the long non-coding RNA MALAT1 in tenofovir-treated pregnant women with hepatitis B virus infection promotes immune recovery of natural killer cells via the has-miR-155-5p/HIF-1α axis. International immunopharmacology, 2022, Volume: 107 Topics: Down-Regulation; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Killer Cells, Natural; MicroRNAs; Pregnancy; Pregnant Women; RNA, Long Noncoding; Tenofovir	2022
Editorial: does TAF have a better or worse safety profile than TDF, to treat hepatitis B? Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:8 Topics: Hepatitis B; Humans; Tenofovir	2022
Editorial: does TAF have a better or worse safety profile than TDF, to treat hepatitis B? Authors' reply. Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:8 Topics: Hepatitis B; Humans; Tenofovir	2022
First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamide. Hepatology communications, 2022, Volume: 6, Issue:8 Topics: Alanine; Antiviral Agents; Hepatitis B; Hepatitis B, Chronic; Humans; Prospective Studies; Retrospective Studies; Tenofovir; United States	2022
The role of tenofovir disoproxil fumarate for preventing vertical transmission of hepatitis B. Antiviral therapy, 2022, Volume: 27, Issue:2 Topics: Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Tenofovir; Viral Load; Viremia	2022
Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection. Alimentary pharmacology & therapeutics, 2022, Volume: 56, Issue:3 Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Female; Hepatitis B; Hepatitis B, Chronic; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Milk, Human; Pregnancy; Tenofovir	2022
Successful Treatment of Tenofovir Alafenamide-Induced Lactic Acidosis: A Case Report. Journal of pharmacy practice, 2023, Volume: 36, Issue:5 Topics: Acidosis, Lactic; Adenine; Antiviral Agents; Hepatitis B; Humans; Male; Middle Aged; Tenofovir	2023
A Study on Pregenomic RNA and Factors Related to Hepatitis B Virus Infection Based on Real World. Frontiers in public health, 2022, Volume: 10 Topics: DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; RNA, Viral; Tenofovir	2022
A carrier-free metal-organic hybrid nanoassembly with combination anti-viral and hepato-protective activity for hepatitis B treatment. Biomaterials science, 2022, Jul-26, Volume: 10, Issue:15 Topics: Adenine; Animals; Antiviral Agents; DNA Replication; DNA, Viral; Hepatitis B; Hepatitis B virus; Inflammation; Mice; Organophosphates; Phosphates; Tenofovir; Virus Replication	2022
Tenofovir Alafenamide use in pregnant women with chronic hepatitis B virus infection: more data needed. Hepatology international, 2022, Volume: 16, Issue:4 Topics: Adenine; Alanine; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Pregnancy; Pregnant Women; Tenofovir	2022
Plasma and breast milk pharmacokinetics of tenofovir alafenamide of mothers with chronic hepatitis B infection-Authors' reply. Alimentary pharmacology & therapeutics, 2022, Volume: 56, Issue:3 Topics: Adenine; Alanine; Antiviral Agents; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Milk, Human; Mothers; Tenofovir	2022
Comparison of tenofovir disoproxil fumarate and telbivudine in preventing hepatitis B transmission in mothers with high viral load. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2023, Volume: 160, Issue:2 Topics: Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Telbivudine; Tenofovir; Viral Load	2023
Awareness and treatment of chronic hepatitis B in Malaysia-findings from a community-based screening campaign. BMC gastroenterology, 2022, Aug-06, Volume: 22, Issue:1 Topics: Adult; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Malaysia; Tenofovir	2022
Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver, 2022, Volume: 42, Issue:11 Topics: Adenine; Alanine; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Kidney; Longitudinal Studies; Maleates; Organophosphonates; Renal Insufficiency, Chronic; Retrospective Studies; Tenofovir; Treatment Outcome	2022
Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out. BMC infectious diseases, 2022, Sep-01, Volume: 22, Issue:1 Topics: Adult; Cohort Studies; Cross-Sectional Studies; Emtricitabine; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Infant; Pre-Exposure Prophylaxis; Pregnancy; Pregnant Women; Prevalence; South Africa; Tenofovir	2022
The Elegance of the Acyclic Nucleoside Phosphonates (ANPs), Honorary Tribute to Antonín Holý, Who Passed Away on 16 July 2012, at the 10th Anniversary of His Death. Viruses, 2022, 09-07, Volume: 14, Issue:9 Topics: Anniversaries and Special Events; Anti-HIV Agents; Antiviral Agents; Cidofovir; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Nucleosides; Organophosphonates; Prodrugs; Tenofovir	2022
[Prevention of Mother-To-Child Transmission of Hepatitis B Virus: Guidelines on Antiviral Prophylaxis in Pregnancy]. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 2023, Volume: 85, Issue:4 Topics: Adult; Antiviral Agents; Female; Germany; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Parturition; Pregnancy; Pregnancy Complications, Infectious; Tenofovir	2023
Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-18, Volume: 76, Issue:4 Topics: Cohort Studies; Coinfection; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Tenofovir; Viral Load	2023
Treating Hepatitis B Virus in Times of COVID-19: The Case for Clinical Pharmacogenomics Research in Tenofovir-Induced Kidney Toxicity. Omics : a journal of integrative biology, 2022, Volume: 26, Issue:11 Topics: Antiviral Agents; COVID-19; DNA, Viral; Ecosystem; Ghana; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kidney; Pharmacogenetics; SARS-CoV-2; Tenofovir	2022
Prospective cohort study of prevention of mother to child transmission of hepatitis B infection and 9 months follow-up of hepatitis B-exposed infants at Ile-Ife, Nigeria. BMJ open, 2022, 11-08, Volume: 12, Issue:11 Topics: Adult; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nigeria; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Tenofovir	2022
Long-Acting Treatments for Hepatitis B. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 11-21, Volume: 75, Issue:Suppl 4 Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Tenofovir	2022
Viral hepatitis in persons living with HIV in the post-COVID era. AIDS reviews, 2023, Volume: 25, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; COVID-19; Drug Users; Hepatitis A; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Sexual and Gender Minorities; Substance Abuse, Intravenous; Tenofovir	2023
Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients with Hepatitis B Following Liver Transplantation. Annals of transplantation, 2023, Apr-21, Volume: 28 Topics: Adenine; Alanine; Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Transplantation; Retrospective Studies; Tenofovir	2023
Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand. BMJ open, 2023, 07-19, Volume: 13, Issue:7 Topics: Antiviral Agents; Cost-Benefit Analysis; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Tenofovir; Thailand; Viral Load	2023
Entecavir versus tenofovir on the recurrence of hepatitis B-related HCC after liver transplantation: A multicenter observational study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2023, Dec-01, Volume: 29, Issue:12 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Tenofovir; Treatment Outcome	2023
Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016. PloS one, 2023, Volume: 18, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Canada; Coinfection; Cross-Sectional Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Male; Middle Aged; Tenofovir	2023
Successful results of early nucleos(t)ide analogue treatment for liver transplantation candidates with severe acute hepatitis B infection. European journal of gastroenterology & hepatology, 2024, Jan-01, Volume: 36, Issue:1 Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tenofovir; Treatment Outcome	2024
Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting. BMC infectious diseases, 2023, Oct-27, Volume: 23, Issue:1 Topics: Child; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Risk Factors; Seroepidemiologic Studies; Tenofovir	2023
Long-term observation on hepatitis B surface antigen seroclearance in therapy experienced HIV/HBV co-infected Chinese. Journal of viral hepatitis, 2020, Volume: 27, Issue:2 Topics: Adult; Anti-HIV Agents; Antiviral Agents; Asian People; China; Coinfection; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Tenofovir; Time Factors; Young Adult	2020
High Rates of Hepatitis B Virus (HBV) Functional Cure Among Human Immunodeficiency Virus-HBV Coinfected Patients on Antiretroviral Therapy in Zambia. The Journal of infectious diseases, 2020, 01-02, Volume: 221, Issue:2 Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Coinfection; Female; Hepatitis B; HIV Infections; Humans; Male; Prospective Studies; Tenofovir; Treatment Outcome; Viral Load; Zambia	2020
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:2 Topics: Adult; Anti-Retroviral Agents; Biomarkers; CD4 Lymphocyte Count; Coinfection; Female; Hemochromatosis; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Immunization Programs; Lamivudine; Male; Retrospective Studies; Seroepidemiologic Studies; Syphilis; Taiwan; Tenofovir; Young Adult	2021
Rapid quantification of tenofovir in umbilical cord plasma and amniotic fluid in hepatitis B mono-infected pregnant women during labor by ultra-performance liquid chromatography/tandem mass spectrometry. Rapid communications in mass spectrometry : RCM, 2020, May-15, Volume: 34, Issue:9 Topics: Amniotic Fluid; Animals; Antiviral Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Fetal Blood; Hepatitis B; Humans; Limit of Detection; Pregnancy; Pregnancy Complications, Infectious; Tandem Mass Spectrometry; Tenofovir; Umbilical Cord	2020
Clinical efficacy and safety in telbivudine- or tenofovir-treated hepatitis B e antigen-positive pregnant women. Antiviral therapy, 2020, Volume: 25, Issue:1 Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Treatment Outcome	2020
Tenofovir prophylaxis for preventing mother-to-child hepatitis B virus transmission in China: A cost-effectiveness analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 95 Topics: Antiviral Agents; China; Cohort Studies; Cost-Benefit Analysis; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunization, Passive; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Quality-Adjusted Life Years; Tenofovir; Viral Load	2020
HBV flare associated with immunosuppressive treatments: it is still dangerous in the third-generation antivirals era. Antiviral therapy, 2020, Volume: 25, Issue:3 Topics: Alanine Transaminase; Antiviral Agents; Female; Guanine; Hepatitis B; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Symptom Flare Up; Tenofovir	2020
Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis. Medicine, 2020, Volume: 99, Issue:19 Topics: Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Meta-Analysis as Topic; Patient Selection; Randomized Controlled Trials as Topic; Systematic Reviews as Topic; Tenofovir	2020
A pharmacokinetic study to guide dosing of tenofovir disoproxil fumarate during different modalities of renal replacement therapy. Clinical biochemistry, 2020, Volume: 83 Topics: Antiviral Agents; Drug Administration Schedule; Hemofiltration; Hepatitis B; Hepatitis B virus; Humans; Kidney Failure, Chronic; Middle Aged; Prospective Studies; Renal Insufficiency; Renal Replacement Therapy; Tenofovir	2020
Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans. Viruses, 2020, 06-11, Volume: 12, Issue:6 Topics: Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Tenofovir; Viral Load; Viremia; Young Adult	2020
The Risk of Acute Kidney Injury in Hepatitis B Virus-Related Acute on Chronic Liver Failure with Tenofovir Treatment. BioMed research international, 2020, Volume: 2020 Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Antiviral Agents; Female; Guanine; Hepatitis B; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Tenofovir; Treatment Outcome	2020
Occult Hepatitis B Virus Infection in Immunized Infants Born to Untreated and Tenofovir-Treated Highly Viremic Mothers. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2021, Volume: 19, Issue:7 Topics: DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Tenofovir	2021
Assessing the association between platelets and immune recovery in HIV/HBV co-infected patients: A long-term cohort in Asia. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2020, Volume: 84 Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Blood Platelets; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cohort Studies; Cyclopropanes; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Immune Reconstitution; Lamivudine; Longitudinal Studies; Male; Platelet Count; Retrospective Studies; Tenofovir	2020
Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation. International journal for equity in health, 2020, 09-10, Volume: 19, Issue:1 Topics: Adult; Antiviral Agents; Child; Female; Health Resources; Health Services Accessibility; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Infectious Disease Transmission, Vertical; Male; Myanmar; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Rural Population; Tenofovir; Thailand; Transients and Migrants; Vaccination	2020
Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction-A Prospective Cohort Study. Journal of acquired immune deficiency syndromes (1999), 2020, 10-01, Volume: 85, Issue:2 Topics: Adenine; Aged; Alanine; Anti-HIV Agents; Female; Glomerular Filtration Rate; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Interrupted Time Series Analysis; Kidney Diseases; Kidney Function Tests; Liver; Male; Middle Aged; Prospective Studies; Tenofovir; Viral Load	2020
Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy. BMJ open, 2020, 09-13, Volume: 10, Issue:9 Topics: Antiviral Agents; Child; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Myanmar; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Thailand; Viral Load	2020
Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy. Journal of clinical pharmacology, 2021, Volume: 61, Issue:3 Topics: Adult; Anti-HIV Agents; Area Under Curve; Drug Interactions; Female; Hepatitis B; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Young Adult	2021
Complex genetic encoding of the hepatitis B virus on-drug persistence. Scientific reports, 2020, 09-23, Volume: 10, Issue:1 Topics: Antiviral Agents; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tenofovir	2020
Tenofovir-disoproxil-fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection. Journal of gastroenterology, 2021, Volume: 56, Issue:2 Topics: Aged; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Lipid Metabolism; Male; Middle Aged; PPAR alpha; Retrospective Studies; Tenofovir	2021
Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data. Viruses, 2020, 11-23, Volume: 12, Issue:11 Topics: Access to Information; Antiviral Agents; Computer Simulation; Databases, Nucleic Acid; Genetic Variation; Genotype; Geography; Global Health; Hepatitis B; Hepatitis B virus; Humans; Sequence Analysis, DNA; Tenofovir	2020
Optimization of the algorithm diagnosis chronic hepatitis B markers in patients with newly diagnosed HIV infection. Klinicheskaia laboratornaia diagnostika, 2020, Sep-16, Volume: 65, Issue:9 Topics: Algorithms; DNA, Viral; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Mutation; Tenofovir	2020
Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group. Infectious diseases in obstetrics and gynecology, 2020, Volume: 2020 Topics: Antiviral Agents; Case-Control Studies; China; DNA, Viral; Drug Administration Schedule; Female; Gestational Age; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; Humans; Immunoglobulins; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Telbivudine; Tenofovir; Treatment Outcome	2020
Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 11-02, Volume: 73, Issue:9 Topics: Alanine; Antiviral Agents; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Tenofovir; Viral Load	2021
A Tenofovir-Loaded Glycyrrhetinic Acid-Modified Cationic Liposome for Targeted Therapy of Hepatitis B Virus. Journal of biomedical nanotechnology, 2020, Oct-01, Volume: 16, Issue:10 Topics: Animals; Antiviral Agents; DNA, Viral; Glycyrrhetinic Acid; Hepatitis B; Hepatitis B virus; Liposomes; Tenofovir	2020
Debate settled for elevated alanine aminotransferase in hepatitis B? The Lancet. Infectious diseases, 2021, Volume: 21, Issue:6 Topics: Alanine Transaminase; Double-Blind Method; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Tenofovir	2021
Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis. BMC pregnancy and childbirth, 2021, Feb-22, Volume: 21, Issue:1 Topics: Adult; Antiviral Agents; Cost-Benefit Analysis; Female; Hepatitis B; Humans; Infectious Disease Transmission, Vertical; Myanmar; Pregnancy; Pregnancy Complications, Infectious; Reproducibility of Results; Rural Population; Tenofovir; Thailand; Viral Load; Young Adult	2021
Progress towards elimination of mother-to-child transmission of hepatitis B virus infection in China: a modelling analysis. Bulletin of the World Health Organization, 2021, Jan-01, Volume: 99, Issue:1 Topics: Adult; Antiviral Agents; China; Disease Eradication; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Immunoglobulins; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir	2021
Prevention of HBV Recurrence After Liver Transplant: Long-Term Results. Transplantation proceedings, 2021, Volume: 53, Issue:5 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Drug Administration Schedule; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Tenofovir	2021
A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus. Scientific reports, 2021, 06-03, Volume: 11, Issue:1 Topics: Antiviral Agents; Binding Sites; Catalytic Domain; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Viral; Genome, Viral; Genomics; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Models, Molecular; Piperazines; Protein Binding; Structure-Activity Relationship; Tenofovir; Virus Replication	2021
Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study. BMC infectious diseases, 2021, Jun-26, Volume: 21, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Cohort Studies; Elasticity Imaging Techniques; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kidney; Liver; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Tenofovir; Treatment Outcome; United Kingdom; Viral Load; Young Adult	2021
Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status. AIDS (London, England), 2021, 08-01, Volume: 35, Issue:10 Topics: Antiviral Agents; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Tenofovir	2021
Predominance of Hepatitis B Virus Genotype A Among Treated HIV Infected Patients Experiencing High Hepatitis B Virus Drug Resistance in Nairobi, Kenya. AIDS research and human retroviruses, 2017, Volume: 33, Issue:9 Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Emtricitabine; Female; Genes, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Kenya; Lamivudine; Male; Middle Aged; Tenofovir; Viral Load; Young Adult	2017
Tenofovir alafenamide for hepatitis B: evolution or revolution? The lancet. Gastroenterology & hepatology, 2016, Volume: 1, Issue:3 Topics: Anti-HIV Agents; Antiviral Agents; Hepatitis B; Hepatitis B, Chronic; HIV Infections; Humans; Tenofovir	2016
Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case report. Journal of medical case reports, 2017, Apr-17, Volume: 11, Issue:1 Topics: Antiviral Agents; Contact Tracing; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Middle Aged; Rituximab; Tenofovir; Treatment Outcome	2017
Is tenofovir the answer to further preventing mother-to-child transmission of hepatitis B? The journal of the Royal College of Physicians of Edinburgh, 2016, Volume: 46, Issue:4 Topics: Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Mothers; Tenofovir	2016
Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes. PloS one, 2017, Volume: 12, Issue:6 Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Cross-Sectional Studies; Female; Gambia; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Mass Screening; Middle Aged; Practice Guidelines as Topic; Tenofovir; Treatment Outcome; Young Adult	2017
Fatal lactic acidosis in hepatitis B virus-associated decompensated cirrhosis treated with tenofovir: A case report. Medicine, 2017, Volume: 96, Issue:25 Topics: Acidosis, Lactic; Antiviral Agents; Fatal Outcome; Hepatitis B; Humans; Liver Cirrhosis; Male; Middle Aged; Renal Dialysis; Tenofovir	2017
Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report. Anticancer research, 2017, Volume: 37, Issue:7 Topics: Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Liver Failure; Middle Aged; Paclitaxel; Tenofovir; Virus Activation	2017
Physician testing for HIV in patients treated with tenofovir disoproxil fumarate and lamivudine monotherapy for hepatitis B virus. Sexual health, 2018, Volume: 15, Issue:1 Topics: AIDS Serodiagnosis; Attitude to Health; Cross-Sectional Studies; Hepatitis B; HIV Infections; Humans; Physician-Patient Relations; Practice Patterns, Physicians'; Reverse Transcriptase Inhibitors; Tenofovir	2018
Letter: role of tenofovir to prevent mother-to-child transmission of hepatitis B virus-authors' reply. Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:5 Topics: Child; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Tenofovir	2017
Letter: role of tenofovir to prevent mother-to-child transmission of hepatitis B virus. Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:5 Topics: Child; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy Complications, Infectious; Tenofovir	2017
Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort. Journal of viral hepatitis, 2018, Volume: 25, Issue:2 Topics: Aged; Alanine Transaminase; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Hepatitis C; Hepatitis C, Chronic; Humans; Liver; Male; Middle Aged; Telbivudine; Tenofovir; United States; Veterans; Virus Activation	2018
Development of a digital droplet PCR assay to measure HBV DNA in patients receiving long-term TDF treatment. Journal of virological methods, 2017, Volume: 249 Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Limit of Detection; Polymerase Chain Reaction; Sensitivity and Specificity; Seroconversion; Tenofovir; Viral Load; Virus Replication	2017
Resolution of acute hepatitis B-associated aplastic anaemia with antiviral therapy. BMJ case reports, 2017, Oct-03, Volume: 2017 Topics: Adult; Anemia, Aplastic; Antiviral Agents; Female; Hepatitis B; Humans; Tenofovir; Treatment Outcome	2017
Cerebellar ataxia and neuropathy as presenting features of hepatitis-B related cirrhosis and portal hypertension. BMJ case reports, 2017, Oct-19, Volume: 2017 Topics: Antiviral Agents; Brain; Cerebellar Ataxia; Hepatitis B; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Middle Aged; Tenofovir	2017
Third-trimester tenofovir to prevent mother-to-child hepatitis B virus transmission. The Indian journal of medical research, 2017, Volume: 146, Issue:1 Topics: Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Tenofovir	2017
Antiviral therapy for hepatitis B virus during second pregnancies. The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:3 Topics: Adult; Antiviral Agents; Female; Gravidity; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Tenofovir	2018
Call to Action: Prevention of Mother-to-Child Transmission of Hepatitis B in Africa. The Journal of infectious diseases, 2018, 03-28, Volume: 217, Issue:8 Topics: Africa South of the Sahara; Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; HIV Infections; Humans; Immunization Programs; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load	2018
Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2018, Volume: 37, Issue:1 Topics: Adolescent; Adult; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk; Tenofovir; Transplants; Virus Activation; Young Adult	2018
Implementing preexposure prophylaxis among key populations: an opportunity for patient-centered services and management of hepatitis B. AIDS (London, England), 2018, 03-27, Volume: 32, Issue:6 Topics: Antiviral Agents; Cote d'Ivoire; Disease Transmission, Infectious; Female; Hepatitis B; HIV Infections; Humans; Male; Pre-Exposure Prophylaxis; Sex Workers; Tenofovir	2018
Viral hepatitis: Maternal tenofovir use does not improve prevention of perinatal HBV transmission. Nature reviews. Gastroenterology & hepatology, 2018, Volume: 15, Issue:5 Topics: Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Tenofovir	2018
Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa. Journal of viral hepatitis, 2018, Volume: 25, Issue:10 Topics: Adult; Africa, Western; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antiviral Agents; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Mutation; Promoter Regions, Genetic; Prospective Studies; Tenofovir	2018
Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana. The Journal of infection, 2018, Volume: 76, Issue:6 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Coinfection; Female; Ghana; Glomerular Filtration Rate; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Proteinuria; Tenofovir; Time Factors	2018
Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2018, Volume: 50, Issue:9 Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies; Tenofovir; Young Adult	2018
HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa. BMC infectious diseases, 2018, 05-08, Volume: 18, Issue:1 Topics: Adult; Antiretroviral Therapy, Highly Active; Biomarkers; CD4-Positive T-Lymphocytes; Coinfection; Elasticity Imaging Techniques; Female; Hepatitis B; HIV Infections; Humans; Lipopolysaccharide Receptors; Liver Cirrhosis; Male; Middle Aged; South Africa; Tenofovir; Viral Load	2018
Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China. International journal of epidemiology, 2018, 10-01, Volume: 47, Issue:5 Topics: Adolescent; Adult; Antiviral Agents; China; Cost-Benefit Analysis; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Tenofovir; Viral Load; Young Adult	2018
Successful Management of De Novo Acute Hepatitis B Virus Infection With Entecavir in a Living-Donor Liver Transplant Patient. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2018, Volume: 16, Issue:5 Topics: Adult; Antiviral Agents; Drug Substitution; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Living Donors; Male; Tenofovir; Time Factors; Treatment Outcome	2018
Tenofovir to Prevent Perinatal Transmission of Hepatitis B. The New England journal of medicine, 2018, 06-14, Volume: 378, Issue:24 Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir	2018
Tenofovir to Prevent Perinatal Transmission of Hepatitis B. The New England journal of medicine, 2018, 06-14, Volume: 378, Issue:24 Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir	2018
Tenofovir to Prevent Perinatal Transmission of Hepatitis B. The New England journal of medicine, 2018, 06-14, Volume: 378, Issue:24 Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir	2018
Tenofovir to Prevent Perinatal Transmission of Hepatitis B. The New England journal of medicine, 2018, 06-14, Volume: 378, Issue:24 Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir	2018
Changes in Liver Tissue Trace Element Concentrations During Hepatitis B Viral Infection Treatment. Biological trace element research, 2019, Volume: 188, Issue:2 Topics: Adult; Antiviral Agents; Biopsy; Female; Fibrosis; Guanine; Hepatitis B; Humans; Lamivudine; Liver; Liver Function Tests; Male; Middle Aged; Telbivudine; Tenofovir; Trace Elements; Young Adult	2019
Tenofovir alafenamide associated fatal lactic acidosis in an autologous hematopoietic stem cell transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:5 Topics: Acidosis, Lactic; Adenine; Aged; Alanine; Antiviral Agents; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis C; HIV Infections; Humans; Male; Multiple Myeloma; Tenofovir; Transplantation, Autologous	2018
Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg-positive cancer patients undergoing chemotherapy. Journal of viral hepatitis, 2018, Volume: 25, Issue:12 Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antiviral Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Humans; Incidence; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Assessment; Tenofovir	2018
Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil. PloS one, 2018, Volume: 13, Issue:9 Topics: Antiviral Agents; Brazil; Coinfection; Disease Transmission, Infectious; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D; Hepatitis Delta Virus; Humans; Interferons; Male; Models, Theoretical; Tenofovir; Viral Load	2018
High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China. Intervirology, 2018, Volume: 61, Issue:3 Topics: Adult; Anti-HIV Agents; China; Coinfection; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Multivariate Analysis; Mutation; Prevalence; Tenofovir; Viral Load	2018
Timely Administration of Birth Dose Hepatitis B Virus Vaccine May Break the Chain of Perinatal Transmission. Hepatology (Baltimore, Md.), 2019, Volume: 69, Issue:5 Topics: Female; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Tenofovir	2019
Letter: chronic kidney disease risk in patients with chronic hepatitis B-authors' reply. Alimentary pharmacology & therapeutics, 2018, Volume: 48, Issue:11-12 Topics: Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Renal Insufficiency, Chronic; Tenofovir	2018
Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load. Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:2 Topics: Adult; Antiviral Agents; Breast Feeding; Female; Follow-Up Studies; Hepatitis B; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Postpartum Period; Prospective Studies; Tenofovir; Viral Load	2019
Vertically acquired occult hepatitis B virus infection may become overt after several years. The Journal of infection, 2019, Volume: 78, Issue:3 Topics: Adult; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Prospective Studies; Sweden; Tenofovir; Young Adult	2019
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir. Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:8 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis D, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Prospective Studies; Tenofovir; Treatment Outcome	2019
Letter: put on your thinking cap - tenofovir disoproxil fumarate for the prevention of vertical transmission of hepatitis B virus. Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:6 Topics: Female; Hepatitis B; Hepatitis B virus; Humans; Mothers; Tenofovir; Thinking; Viral Load	2019
Letter: put on your thinking cap - tenofovir disoproxil fumarate for the prevention of vertical transmission of hepatitis B virus. Author's reply. Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:6 Topics: Female; Hepatitis B; Hepatitis B virus; Humans; Mothers; Tenofovir; Thinking; Viral Load	2019
Reactivation of Hepatitis B Virus Infection With Reverse Seroconversion Following Umbilical Cord Allogeneic Hematopoietic Cell Transplantation in a Hepatitis-B-Immune Patient: A Case Report. Transplantation proceedings, 2019, Volume: 51, Issue:2 Topics: Aged; Antiviral Agents; Cord Blood Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Male; Seroconversion; Tenofovir; Virus Activation	2019
Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy. Medicine, 2019, Volume: 98, Issue:14 Topics: Adolescent; Adult; Antiviral Agents; Case-Control Studies; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Retrospective Studies; Telbivudine; Tenofovir; Viral Load; Young Adult	2019
Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies. Journal of hepatology, 2019, Volume: 71, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Carcinoma, Hepatocellular; Coinfection; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Tenofovir	2019
[Hepatitis B and renal failure: prevalence and associated factors in National University Hospital Center of Cotonou]. The Pan African medical journal, 2018, Volume: 31 Topics: Adolescent; Adult; Age Factors; Aged; Antiviral Agents; Benin; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Hepatitis B; Hepatitis B Surface Antigens; Hospitals, University; Humans; Hypertension; Male; Middle Aged; Prevalence; Renal Insufficiency; Risk Factors; Tenofovir; Young Adult	2018
Successful treatment of HBV, HCV, & HEV, with 12-week long use of tenofovir, sofosbuvir, daclatasvir, and ribavirin: A case report. Journal of infection and public health, 2020, Volume: 13, Issue:1 Topics: Aged; Antiviral Agents; Asthma; Carbamates; Coinfection; Diabetes Complications; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis C, Chronic; Hepatitis E; Humans; Imidazoles; Male; Pyrrolidines; Ribavirin; Sofosbuvir; Tenofovir; Treatment Outcome; Valine; Viral Load	2020
Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa. BMC public health, 2019, Jun-26, Volume: 19, Issue:1 Topics: Adult; Antiviral Agents; Child; Cost-Benefit Analysis; Developing Countries; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infectious Disease Transmission, Vertical; Mass Screening; Models, Biological; Pregnancy; Pregnancy Complications, Infectious; South Africa; Tenofovir; Vaccination; Young Adult	2019
Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis. Viruses, 2019, 06-19, Volume: 11, Issue:6 Topics: Administration, Intravaginal; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Mutation; Pre-Exposure Prophylaxis; South Africa; Tenofovir; Young Adult	2019
Fanconi syndrome due to tenofovir disoproxil fumarate (TDF) after liver transplantation. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019, Volume: 51, Issue:9 Topics: Antiviral Agents; Fanconi Syndrome; Hepatitis B; Humans; Liver Transplantation; Male; Middle Aged; Tenofovir; Transplant Recipients	2019
Brief Report: Relationship Between ABCC4 SNPs and Hepatitis B Virus Suppression During Tenofovir-Containing Antiretroviral Therapy in Patients With HIV/HBV Coinfection. Journal of acquired immune deficiency syndromes (1999), 2019, 12-01, Volume: 82, Issue:4 Topics: Adult; Anti-HIV Agents; Coinfection; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Logistic Models; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Polymorphism, Single Nucleotide; Tenofovir	2019
Letter: tenofovir disoproxil fumarate is safe for prevention of mother-to-child transmission of hepatitis B virus. Alimentary pharmacology & therapeutics, 2019, Volume: 50, Issue:4 Topics: Child; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Tenofovir; Viral Load	2019
Letter: tenofovir disoproxil fumarate is safe for prevention of mother-to-child transmission of hepatitis B virus. Authors' reply. Alimentary pharmacology & therapeutics, 2019, Volume: 50, Issue:4 Topics: Child; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Tenofovir; Viral Load	2019
Prophylactic effect of antiretroviral therapy on hepatitis B virus infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:12 Topics: Adenine; Adult; Alanine Transaminase; Anti-Retroviral Agents; Antibiotic Prophylaxis; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Organophosphonates; Retrospective Studies; Tenofovir	2013
Prevention of de novo hepatitis B with adefovir plus vaccination in recipients of liver transplants from core antibody-positive donors. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013, Volume: 19, Issue:4 Topics: Adenine; Adult; Aged; Antiviral Agents; Biomarkers; Deoxycytidine; DNA, Viral; Drug Substitution; Emtricitabine; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Liver Transplantation; Middle Aged; Organophosphonates; Tenofovir; Time Factors; Tissue Donors; Treatment Outcome	2013
Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience. Transplantation, 2013, Apr-15, Volume: 95, Issue:7 Topics: Adenine; Adult; Aged; Analysis of Variance; Antiviral Agents; Biomarkers; Chi-Square Distribution; DNA, Viral; Donor Selection; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Logistic Models; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Tenofovir; Time Factors; Tissue Donors; Treatment Outcome; Viral Load	2013
Tenofovir treatment of the severe acute hepatitis B. Revista espanola de enfermedades digestivas, 2013, Volume: 105, Issue:1 Topics: Acute Disease; Adenine; Antiviral Agents; Hepatitis B; Humans; Male; Middle Aged; Organophosphonates; Severity of Illness Index; Tenofovir	2013
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy. BMC research notes, 2013, Apr-17, Volume: 6 Topics: Adenine; Adult; Anti-Retroviral Agents; Coinfection; Cross-Sectional Studies; Deoxycytidine; Emtricitabine; Europe; Female; Guideline Adherence; Health Services Accessibility; Hepatitis B; HIV Infections; Humans; Infectious Disease Medicine; Italy; Lamivudine; Male; Multivariate Analysis; Organophosphonates; Practice Guidelines as Topic; Regression Analysis; Tenofovir; Treatment Outcome	2013
Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation. Pharmacotherapy, 2013, Volume: 33, Issue:9 Topics: Adenine; Adult; Antiviral Agents; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B; Humans; Liver Transplantation; Male; Middle Aged; Organophosphonates; Secondary Prevention; Tenofovir	2013
Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013, Volume: 19, Issue:9 Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppression Therapy; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome	2013
WHO survey finds half of countries do not have clinical guidelines for treating hepatitis. BMJ (Clinical research ed.), 2013, Jul-24, Volume: 347 Topics: Adenine; Antiviral Agents; Drugs, Essential; Global Health; Guanine; Health Priorities; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Organophosphonates; Polyethylene Glycols; Practice Guidelines as Topic; Recombinant Proteins; Tenofovir; World Health Organization	2013
HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes. Journal of acquired immune deficiency syndromes (1999), 2013, Oct-01, Volume: 64, Issue:2 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; South Africa; Tenofovir; Treatment Outcome; Zambia	2013
HBV clinical isolates expressing adefovir resistance mutations show similar tenofovir susceptibilities across genotypes B, C and D. Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34, Issue:7 Topics: Adenine; Base Sequence; Cloning, Molecular; DNA Primers; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation, Missense; Organophosphonates; Sequence Analysis, DNA; Tenofovir	2014
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. World journal of gastroenterology, 2013, Dec-28, Volume: 19, Issue:48 Topics: Adenine; Antiviral Agents; Biomarkers; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunization Schedule; Immunoglobulins; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Tenofovir; Time Factors; Treatment Outcome; Turkey; Viral Load	2013
Lamivudine compared with newer antivirals for prophylaxis of hepatitis B core antibody positive livers: a cost-effectiveness analysis. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014, Volume: 14, Issue:3 Topics: Adenine; Antiviral Agents; Cohort Studies; Cost-Benefit Analysis; Decision Trees; Follow-Up Studies; Graft Survival; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Markov Chains; Organophosphonates; Prognosis; Quality-Adjusted Life Years; Survival Rate; Tenofovir	2014
Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy. Journal of viral hepatitis, 2014, Volume: 21, Issue:4 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Tenofovir; Viral Load; Viremia	2014
Clinical problem-solving. Wasting away. The New England journal of medicine, 2014, Mar-06, Volume: 370, Issue:10 Topics: Adenine; Adult; Bone Diseases, Metabolic; Cachexia; Diagnosis, Differential; Fanconi Syndrome; Female; Hepatitis B; Humans; Hypophosphatemia; Liver Function Tests; Organophosphonates; Pelvic Bones; Phosphates; Radiography; Reverse Transcriptase Inhibitors; Tenofovir	2014
Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort. Journal of acquired immune deficiency syndromes (1999), 2014, Jun-01, Volume: 66, Issue:2 Topics: Adenine; Adult; Antibodies, Viral; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; Deoxycytidine; DNA, Viral; Emtricitabine; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Middle Aged; Organophosphonates; Randomized Controlled Trials as Topic; Retrospective Studies; Tenofovir; United States	2014
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. Journal of hepatology, 2014, Volume: 61, Issue:3 Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; Female; Gastrointestinal Diseases; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Tenofovir; Time Factors; Treatment Outcome; Viral Load	2014
Tenofovir disoproxil fumarate rescue therapy for HBV recurrence in two liver transplant recipients with previous multiple nucleo(s/t)ide treatment failures. Transplant international : official journal of the European Society for Organ Transplantation, 2014, Volume: 27, Issue:10 Topics: Adenine; Aged; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis B; Humans; Liver Failure; Liver Function Tests; Liver Transplantation; Male; Nucleotides; Organophosphonates; Recurrence; Retreatment; Risk Assessment; Tenofovir; Transplant Recipients; Treatment Failure; Treatment Outcome	2014
An HBV-HIV co-infected patient treated with tenofovir-based therapy who achieved HBs antigen/antibody seroconversion. Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:12 Topics: Adenine; Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Coinfection; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; HIV Infections; Humans; Male; Organophosphonates; Tenofovir	2014
The role of tenofovir in preventing and treating hepatitis B virus (HBV) reactivation in immunosuppressed patients. A real life experience from a tertiary center. European journal of internal medicine, 2014, Volume: 25, Issue:8 Topics: Adenine; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Female; Hepatitis B; Humans; Immunocompromised Host; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Organophosphonates; Rituximab; Tenofovir; Virus Activation	2014
First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy. Hepatology (Baltimore, Md.), 2015, Volume: 62, Issue:1 Topics: Adenine; Adult; Coinfection; Hepatitis B; Hepatitis D; Humans; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2015
Postexposure prophylactic effect of hepatitis B virus (HBV)-active antiretroviral therapy against HBV infection. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:2 Topics: Adenine; Animals; Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mice; Organophosphonates; Retrospective Studies; Tenofovir	2015
The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:4 Topics: Adult; Anti-Retroviral Agents; Coinfection; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Kinetics; Male; Middle Aged; Retrospective Studies; RNA, Viral; Tenofovir; Viral Load; Young Adult	2015
The efficacy and safety of tenofovir in the prevention of hepatitis B virus recurrence following liver transplantation. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2014, Volume: 25, Issue:6 Topics: Adenine; Antiviral Agents; End Stage Liver Disease; Female; Hepatitis B; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Retrospective Studies; Tenofovir; Treatment Outcome	2014
Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis? Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3 Topics: Adenine; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir	2015
Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation. Transplantation proceedings, 2015, Volume: 47, Issue:2 Topics: Adenine; Adult; Aged; Antiviral Agents; Cost-Benefit Analysis; Drug Costs; Female; Graft Survival; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome; United States	2015
Dramatic Improvement of Chronic Inflammatory Demyelinating Polyneuropathy Through Tenofovir Treatment in a Patient Infected with Hepatitis B Virus. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2015, Volume: 10, Issue:2 Topics: Adult; Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Male; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Tenofovir; Treatment Outcome	2015
Efficacy and safety of lamivudine or tenofovir plus intramuscular hepatitis B immunoglobulin in prevention of hepatitis B virus reinfection after liver transplant. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2015, Volume: 13 Suppl 1 Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tenofovir; Time Factors; Treatment Outcome; Virus Activation; Young Adult	2015
Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation. Digestive diseases and sciences, 2015, Volume: 60, Issue:9 Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir	2015
A LC-MS method to quantify tenofovir urinary concentrations in treated patients. Journal of pharmaceutical and biomedical analysis, 2015, Oct-10, Volume: 114 Topics: Antiretroviral Therapy, Highly Active; Calibration; Chromatography; Chromatography, Liquid; Drug Monitoring; Hepatitis B; HIV Infections; Humans; Limit of Detection; Mass Spectrometry; Reproducibility of Results; Tenofovir; United States; United States Food and Drug Administration; Urinalysis	2015
Tenofovir-best hope for treatment of chronic hepatitis B infection? The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2015, Volume: 26, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Seroconversion; Tenofovir; Treatment Outcome; Young Adult	2015
Tenofovir-based antiretroviral therapy in  HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database. Antiviral therapy, 2016, Volume: 21, Issue:1 Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Biomarkers; CD4 Lymphocyte Count; Cohort Studies; Coinfection; Databases, Factual; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Kidney Function Tests; Liver Function Tests; Male; Mortality; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir; Treatment Outcome	2016
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons. BMC gastroenterology, 2015, Jul-08, Volume: 15 Topics: Adult; Aged; Antiviral Agents; Coinfection; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Switzerland; Tenofovir; Viral Load; Young Adult	2015
Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV. Antiviral therapy, 2015, Volume: 20, Issue:7 Topics: Adult; Antiviral Agents; Biomarkers; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Treatment Outcome; Viral Load; Virus Replication	2015
Tenofovir disoproxil treatment for a HIV-hepatitis B virus coinfected patient undergoing peritoneal dialysis: which dose do we need? AIDS (London, England), 2015, Jul-31, Volume: 29, Issue:12 Topics: Antiviral Agents; Coinfection; Hemodialysis Solutions; Hepatitis B; HIV Infections; Humans; Peritoneal Dialysis; Renal Insufficiency; Serum; Tenofovir	2015
Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa. Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:3 Topics: Africa; Antiviral Agents; Biomarkers; Cohort Studies; Coinfection; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tenofovir; Time Factors	2016
Mechanism of Adefovir, Tenofovir and Entecavir Resistance: Molecular Modeling Studies of How A Novel Anti-HBV Agent (FMCA) Can Overcome the Drug Resistance. Current medicinal chemistry, 2015, Volume: 22, Issue:34 Topics: Adenine; Adenosine; Amino Acid Sequence; Antiviral Agents; Binding Sites; Catalytic Domain; Databases, Protein; Drug Resistance, Viral; Gene Products, pol; Guanine; Hepatitis B; Hepatitis B virus; HIV Reverse Transcriptase; Humans; Hydrogen Bonding; Molecular Dynamics Simulation; Molecular Sequence Data; Mutation; Organophosphonates; Sequence Alignment; Tenofovir	2015
Tenofovir-induced severe hepatitis in occult hepatitis B reactivation. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:10 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Doxorubicin; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Liver Function Tests; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Tenofovir; Vincristine; Virus Activation	2015
Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up. PloS one, 2015, Volume: 10, Issue:10 Topics: Adult; Antiviral Agents; Biomarkers; DNA, Viral; Female; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Tenofovir; Time Factors; Viral Load; Viral Proteins; Young Adult	2015
Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D. European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:1 Topics: Adult; Albuminuria; Alkaline Phosphatase; Antiviral Agents; beta 2-Microglobulin; Creatinine; Cystatin C; Electrolytes; Female; Glomerular Filtration Rate; Hepatitis B; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Renal Insufficiency; Serum Albumin; Tenofovir; Urea; Uric Acid; Vitamin D	2016
Hepatitis B in rugby: is it time to revisit policy? British journal of sports medicine, 2016, Volume: 50, Issue:11 Topics: Antiviral Agents; Athletes; Football; Hepatitis B; Hepatitis B Vaccines; Humans; Male; Risk; Tenofovir	2016
Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:1 Topics: Adult; Antiviral Agents; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver; Male; Middle Aged; Postoperative Complications; Tenofovir; Tissue Donors; Transplant Recipients	2016
Lamivudine Monotherapy-Based cART Is Efficacious for HBV Treatment in HIV/HBV Coinfection When Baseline HBV DNA <20,000 IU/mL. Journal of acquired immune deficiency syndromes (1999), 2016, May-01, Volume: 72, Issue:1 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; China; Cohort Studies; Coinfection; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Tenofovir	2016
Novel quantification of tenofovir disoproxil fumarate adherence in human immunodeficiency virus/hepatitis B coinfected patients with incomplete hepatitis B virus viral suppression. Hepatology (Baltimore, Md.), 2016, Volume: 64, Issue:3 Topics: Antiviral Agents; Coinfection; Defective Viruses; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Tenofovir	2016
[Novel therapeutic drugs GSK548470 (Tenofovir)]. Nihon rinsho. Japanese journal of clinical medicine, 2015, Volume: 73 Suppl 9 Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Tenofovir	2015
Analysis of hepatitis B virus genotype changes in patients with chronic hepatitis B infection on tenofovir therapy. Journal of medical virology, 2016, Volume: 88, Issue:8 Topics: Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Genetic Variation; Genotype; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Tenofovir; Young Adult	2016
Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis. The Journal of infectious diseases, 2016, Aug-15, Volume: 214, Issue:4 Topics: Adult; Antiviral Agents; Chemoprevention; Emtricitabine; Female; Follow-Up Studies; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Prospective Studies; Tenofovir	2016
Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients. Journal of hepatology, 2016, Volume: 65, Issue:4 Topics: Antiviral Agents; Coinfection; DNA, Circular; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Tenofovir	2016
The hidden threat of hepatitis B. The Lancet. Global health, 2016, Volume: 4, Issue:8 Topics: Antiviral Agents; Disease Eradication; Hepatitis B; Humans; Mass Screening; Tenofovir; World Health Organization	2016
Tenofovir for Prevention of Mother to Child Transmission of Hepatitis B, Evidence based Medicine Viewpoint. Indian pediatrics, 2016, Oct-08, Volume: 53, Issue:10 Topics: Antiviral Agents; Child; Evidence-Based Medicine; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy Complications, Infectious; Tenofovir	2016
Tenofovir for Prevention of Mother to Child Transmission of Hepatitis B, Obstetricians Viewpoint. Indian pediatrics, 2016, Oct-08, Volume: 53, Issue:10 Topics: Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy Complications, Infectious; Tenofovir	2016
Tenofovir for Prevention of Mother to Child Transmission of Hepatitis B,Neonatologists Viewpoint. Indian pediatrics, 2016, Oct-08, Volume: 53, Issue:10 Topics: Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Neonatologists; Pregnancy Complications, Infectious; Tenofovir	2016
Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting. Clinical and experimental pharmacology & physiology, 2017, Volume: 44, Issue:2 Topics: Adult; Antiviral Agents; Coinfection; Creatinine; Dose-Response Relationship, Drug; Female; Genotype; Glomerular Filtration Rate; Hepatitis B; HIV Infections; Humans; Kidney; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Tenofovir; Time Factors	2017
Pre-exposure prophylaxis failure with tenofovir disoproxil. AIDS (London, England), 2017, 01-02, Volume: 31, Issue:1 Topics: Adult; Anti-HIV Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Male; Pre-Exposure Prophylaxis; RNA, Viral; Syphilis; Tenofovir; Treatment Failure; Viral Load	2017
Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents. The Pediatric infectious disease journal, 2017, Volume: 36, Issue:4 Topics: Adolescent; Adult; Antiviral Agents; Child; Coinfection; DNA, Viral; Hepatitis B; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Prospective Studies; Tenofovir; Young Adult	2017
Tenofovir alafenamide demonstrates broad cross-genotype activity against wild-type HBV clinical isolates and maintains susceptibility to drug-resistant HBV isolates in vitro. Antiviral research, 2017, Volume: 139 Topics: Adenine; Alanine; Antiviral Agents; Drug Resistance, Viral; Genotype; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Mutagenesis, Site-Directed; Phenotype; Prodrugs; Tenofovir; Virus Replication	2017
Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection. PloS one, 2016, Volume: 11, Issue:12 Topics: Adult; Coinfection; Drug Combinations; Drug Resistance, Viral; Endemic Diseases; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Tenofovir; Treatment Outcome	2016
Hepatitis B Leading to Megaloblastic Anemia and Catastrophic Peripheral Thrombocytopenia. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2016, Volume: 26, Issue:12 Topics: Adult; Anemia, Megaloblastic; Benzoates; Folic Acid; Folic Acid Deficiency; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Hydrazines; Male; Platelet Count; Polymerase Chain Reaction; Pyrazoles; Tenofovir; Thrombocytopenia; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B Complex	2016
[Spontaneous remission of HCV infection after autologous stem cell transplantation in a 58-year-old man]. Der Internist, 2017, Volume: 58, Issue:6 Topics: Antiviral Agents; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Male; Middle Aged; Multiple Myeloma; Remission, Spontaneous; Stem Cell Transplantation; Tenofovir; Virus Activation	2017
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations. HIV medicine, 2009, Volume: 10, Issue:4 Topics: Adenine; Adult; Aged; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cross-Sectional Studies; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Polymerase Chain Reaction; Retrospective Studies; Tenofovir; Viral Load; Viremia	2009
Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort. HIV medicine, 2009, Volume: 10, Issue:5 Topics: Adenine; Adult; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Treatment Outcome; Virus Replication	2009
Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients. World journal of gastroenterology, 2009, Feb-14, Volume: 15, Issue:6 Topics: Adenine; Adult; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Viral Proteins	2009
The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains. Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:4 Topics: Adenine; Anti-HIV Agents; Cell Line, Tumor; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine; Viral Proteins; Virus Replication	2009
Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab. Iranian journal of immunology : IJI, 2009, Volume: 6, Issue:1 Topics: Adenine; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antiviral Agents; Behcet Syndrome; Hepatitis B; HLA-B Antigens; Humans; Infliximab; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Tumor Necrosis Factor-alpha; Viral Load	2009
Emergency transplantation for acute reactivation of chronic hepatitis B with high viral load: role of antiviral therapy. Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29, Issue:5 Topics: Adenine; Blood Chemical Analysis; DNA, Viral; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Secondary Prevention; Tenofovir; Ultrasonography; Viral Load	2009
Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir. Journal of viral hepatitis, 2009, Volume: 16, Issue:7 Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Female; Glomerular Filtration Rate; Hepatitis B; HIV Infections; Humans; Longitudinal Studies; Male; Middle Aged; Organophosphonates; Tenofovir; Treatment Outcome; Viral Load	2009
[Failure to treat hepatitis B virus infection with adefovir due to early selection of rtA181T mutation]. Medicina clinica, 2010, Apr-10, Volume: 134, Issue:10 Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; Humans; Male; Middle Aged; Mutation; Organophosphonates; Phenotype; Tenofovir; Time Factors; Treatment Failure	2010
High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy. HIV medicine, 2010, Volume: 11, Issue:1 Topics: Adenine; Adult; Age Factors; Anti-HIV Agents; Anti-Retroviral Agents; Cameroon; Comorbidity; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Hepatitis C Antibodies; HIV Infections; HIV-1; Humans; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Pregnancy; Retrospective Studies; Tenofovir; Transaminases	2010
[Tenofovir, An antiviral agent with activity against HIV infections and hepatitis B]. Revue de l'infirmiere, 2009, Issue:153 Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Organophosphonates; Patient Education as Topic; Tenofovir; Virus Replication	2009
Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2010, Volume: 47, Issue:1 Topics: Adenine; Antibodies, Viral; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; RNA, Viral; Tenofovir; Treatment Outcome	2010
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues. Hepatology (Baltimore, Md.), 2010, Volume: 51, Issue:1 Topics: Adenine; Adolescent; Adult; Cohort Studies; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome	2010
[Protocol for the antiviral therapy of hepatitis B and D]. Orvosi hetilap, 2010, Jan-03, Volume: 151, Issue:1 Topics: Adenine; Antiviral Agents; Biopsy; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis D; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Lamivudine; Liver Cirrhosis; Nucleotides; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir	2010
Viral resistance in hepatitis B: prevalence and management. Current gastroenterology reports, 2010, Volume: 12, Issue:1 Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Genetic Testing; Genotype; Guanine; Hepatitis B; Humans; Lamivudine; Nucleosides; Organophosphonates; Phenotype; Pyrimidinones; Telbivudine; Tenofovir; Thymidine	2010
Drug therapy: tenofovir. Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:2 Topics: Adenine; Antiviral Agents; Female; Hepatitis B; Humans; Middle Aged; Organophosphonates; Tenofovir	2010
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. Journal of viral hepatitis, 2011, Volume: 18, Issue:6 Topics: Adenine; Adult; Aged; Antiviral Agents; Asian People; DNA, Circular; DNA, Viral; Drug Resistance; Female; Gene Products, pol; Genetic Variation; Genome, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Organophosphonates; Phylogeny; Tenofovir; Trans-Activators; Viral Envelope Proteins; Viral Regulatory and Accessory Proteins; Virus Replication	2011
High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B. Journal of medical virology, 2010, Volume: 82, Issue:9 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brazil; Comorbidity; Cross-Sectional Studies; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Tenofovir; Viral Core Proteins; Viral Load; Viral Proteins	2010
Efficacy and safety of entecavir and/or tenofovir for prophylaxis and treatment of hepatitis B recurrence post-liver transplant. Transplantation proceedings, 2010, Volume: 42, Issue:8 Topics: Adenine; Adult; Aged; Antiviral Agents; Combined Modality Therapy; Female; Guanine; Hepatitis B; Humans; Liver Transplantation; Male; Middle Aged; Organophosphonates; Secondary Prevention; Tenofovir	2010
Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients. World journal of gastroenterology, 2010, Nov-21, Volume: 16, Issue:43 Topics: Adenine; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome	2010
Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only. Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:3 Topics: Adenine; Antiviral Agents; Combined Modality Therapy; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Perioperative Care; Secondary Prevention; Tenofovir; Treatment Outcome	2011
Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs. Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:6 Topics: Adenine; Adult; Elasticity Imaging Techniques; Female; Hepatitis B; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors	2011
Successful tenofovir treatment for fulminant hepatitis B infection in an infant. The Pediatric infectious disease journal, 2011, Volume: 30, Issue:10 Topics: Adenine; Antiviral Agents; Female; Hepatitis B; Humans; Infant; Organophosphonates; Tenofovir; Treatment Outcome	2011
Membranous nephropathy in an HIV-positive patient complicated with hepatitis B virus infection. Clinical and experimental nephrology, 2011, Volume: 15, Issue:5 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deoxycytidine; Emtricitabine; Glomerulonephritis, Membranous; Hepatitis B; HIV Infections; Humans; Male; Nephrotic Syndrome; Organophosphonates; Prednisolone; Tenofovir	2011
Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy. Transplant infectious disease : an official journal of the Transplantation Society, 2012, Volume: 14, Issue:1 Topics: Adenine; Age of Onset; Antiviral Agents; Drug Therapy, Combination; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Middle Aged; Organophosphonates; Tenofovir; Transplantation, Homologous; Treatment Outcome; Virus Activation	2012
Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion. Journal of medicinal chemistry, 2011, Aug-25, Volume: 54, Issue:16 Topics: Adenine; Animals; Antiviral Agents; Biological Availability; Drug Design; Drug Resistance, Viral; Guanine; Hep G2 Cells; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Mice; Models, Chemical; Molecular Structure; Mutation; Organophosphonates; Pyrimidines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tenofovir; Tetrazoles	2011
HIV-HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 52, Issue:3 Topics: Adenine; Antiviral Agents; Coinfection; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; HIV Infections; HIV-1; Humans; Male; Middle Aged; Mutation; Organophosphonates; Tenofovir; Viral Load; Viremia	2011
Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:1 Topics: Adenine; Adult; Anti-HIV Agents; Coinfection; Deoxycytidine; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Retrospective Studies; Tenofovir; Time Factors; Treatment Outcome	2012
Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus. Clinical and vaccine immunology : CVI, 2012, Volume: 19, Issue:2 Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Coinfection; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Reagent Kits, Diagnostic; Tenofovir	2012
Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:7 Topics: Adenine; Adult; Antiviral Agents; Deoxycytidine; Emtricitabine; Female; Hepatitis B; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Organophosphonates; Secondary Prevention; Tenofovir	2012
Severe vitamin D deficiency in a patient treated for hepatitis B with tenofovir. International journal of STD & AIDS, 2012, Volume: 23, Issue:1 Topics: Adenine; Hepatitis B; Humans; Hypophosphatemia; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Vitamin D Deficiency	2012
[Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis]. Orvosi hetilap, 2012, Mar-11, Volume: 153, Issue:10 Topics: Adenine; Antiviral Agents; Comorbidity; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Guanine; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Hungary; Interferon-alpha; Interferons; Lamivudine; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; RNA, Viral; Tenofovir; Time Factors; Treatment Outcome	2012
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation. Transplant infectious disease : an official journal of the Transplantation Society, 2012, Volume: 14, Issue:5 Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Nucleotides; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome; Young Adult	2012
Five-year review of HIV-hepatitis B virus (HBV) co-infected patients in a New York City AIDS center. Journal of Korean medical science, 2012, Volume: 27, Issue:7 Topics: Adenine; Adult; Anti-HIV Agents; Coinfection; Female; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; New York City; Organophosphonates; Retrospective Studies; Tenofovir	2012
Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy. Antiviral therapy, 2012, Volume: 17, Issue:6 Topics: Adenine; Adult; Aged; Antiviral Agents; Cloning, Molecular; DNA, Viral; Drug Resistance, Viral; Drug Substitution; Escherichia coli; Evolution, Molecular; Female; Follow-Up Studies; Gene Products, pol; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Tenofovir; Viremia	2012
Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection? Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 12 Topics: Acute Disease; Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis D; Hepatitis Delta Virus; Humans; Interferons; Lamivudine; Male; Organophosphonates; RNA, Viral; Superinfection; Tenofovir; Young Adult	2012
Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12 Topics: Adenine; Animals; Antiviral Agents; Cell Line; Deoxycytidine; Drug Combinations; Drug Interactions; Emtricitabine; Hepatitis B; Hepatitis B virus; Mice; Mice, Nude; Organophosphonates; Phosphorylation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Tenofovir; Viremia; Virus Replication	2012
Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients. Journal of viral hepatitis, 2012, Volume: 19, Issue:11 Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Coinfection; Deoxycytidine; Emtricitabine; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load; Virus Replication	2012
Blunted fetal growth by tenofovir in late pregnancy. AIDS (London, England), 2012, Oct-23, Volume: 26, Issue:16 Topics: Adenine; Adult; Anti-HIV Agents; Asian People; Bone Density; Female; Fetal Growth Retardation; Hepatitis B; HIV Seropositivity; Humans; Infant, Newborn; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir	2012
Severe acute hepatitis B in a treatment-naïve patient with antiviral drug resistant mutations in the polymerase gene. Journal of medical virology, 2013, Volume: 85, Issue:2 Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Mutation, Missense; Organophosphonates; Telbivudine; Tenofovir; Thailand; Thymidine; Travel; Treatment Outcome	2013
The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovir. Antiviral research, 2013, Volume: 97, Issue:2 Topics: Adenine; Amino Acid Substitution; Animals; Antiviral Agents; Computational Biology; Disease Models, Animal; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutant Proteins; Organophosphonates; RNA-Directed DNA Polymerase; Tenofovir	2013
Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient. Journal of medical virology, 2013, Volume: 85, Issue:4 Topics: Adenine; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; DNA, Viral; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunologic Factors; Lymphoma; Male; Organophosphonates; Papua New Guinea; Phylogeny; Rituximab; Sequence Analysis, DNA; Tenofovir; Viral Load; Virus Activation	2013
Sexually transmitted infection with an immune-escape mutant hepatitis B virus in an hepatitis B virus-vaccinated individual with acute HIV-hepatitis C virus infection. AIDS (London, England), 2013, Feb-20, Volume: 27, Issue:4 Topics: Acute Disease; Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Darunavir; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis C; HIV Seropositivity; Homosexuality, Male; Humans; Male; Organophosphonates; Sulfonamides; Tenofovir; Treatment Outcome; Unsafe Sex; Viral Load	2013
Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection. Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:2 Topics: Adenine; Antiviral Agents; Child, Preschool; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Organophosphonates; Tenofovir; Treatment Outcome	2013
Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication. Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:2 Topics: Adenine; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir; Virus Replication	2002
Editorial comment: a tale of two viruses. The AIDS reader, 2002, Volume: 12, Issue:10 Topics: Adenine; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; HIV Infections; Humans; Lamivudine; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir	2002
Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus. The New England journal of medicine, 2003, Jan-09, Volume: 348, Issue:2 Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Tenofovir	2003
Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation. Gastroenterology, 2003, Volume: 124, Issue:2 Topics: Adenine; Antiviral Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Virus Activation	2003
Tenofovir helps beat hepatitis B. TreatmentUpdate, 2003, Volume: 15, Issue:1 Topics: Adenine; Antiviral Agents; CD4 Lymphocyte Count; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Male; Organophosphonates; Organophosphorus Compounds; Tenofovir; Viral Load	2003
Antiviral Research--16th Annual International Conference. Satellite symposium: clinical update on antiviral drugs. 27 April-1 May 2003, Savannah, GA, USA. IDrugs : the investigational drugs journal, 2003, Volume: 6, Issue:6 Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Clinical Trials as Topic; Enfuvirtide; Ganciclovir; Hepatitis B; HIV Envelope Protein gp41; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Peptide Fragments; Tenofovir; Valganciclovir	2003
Antiretroviral therapy and HIV/hepatitis B virus coinfection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Mar-01, Volume: 38 Suppl 2 Topics: Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Organophosphonates; Organophosphorus Compounds; Tenofovir	2004
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir. Antiviral therapy, 2004, Volume: 9, Issue:3 Topics: Adenine; Adult; Antiviral Agents; Cell Line; DNA-Directed DNA Polymerase; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Middle Aged; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Transfection; Virus Replication	2004
Tenofovir therapy for lamivudine resistance following liver transplantation. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:12 Topics: Adenine; Adult; Antiviral Agents; Chronic Disease; Drug Resistance, Viral; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Organophosphonates; Retrospective Studies; Salvage Therapy; Tenofovir; Treatment Outcome	2004
Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment. AIDS (London, England), 2004, Nov-19, Volume: 18, Issue:17 Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Chronic Disease; DNA-Directed DNA Polymerase; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load	2004
Tenofovir helpful for patients with HBV. AIDS patient care and STDs, 2005, Volume: 19, Issue:5 Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Hepatitis B; HIV Infections; Humans; Organophosphonates; Randomized Controlled Trials as Topic; Tenofovir	2005
Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results. Transplant international : official journal of the European Society for Organ Transplantation, 2005, Volume: 18, Issue:7 Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Waiting Lists	2005
Reactivation of viral replication after replacement of tenofovir by adefovir. Hepatology (Baltimore, Md.), 2005, Volume: 42, Issue:1 Topics: Adenine; Adult; Antiviral Agents; Hepatitis B; Humans; Male; Middle Aged; Organophosphonates; Tenofovir; Treatment Failure; Treatment Outcome; Virus Activation	2005
Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2006, Volume: 36, Issue:1 Topics: Adenine; Adult; Anti-HIV Agents; DNA, Viral; Drug Resistance, Viral; Genetic Variation; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Kinetics; Lamivudine; Male; Middle Aged; Organophosphonates; RNA, Viral; Tenofovir	2006
Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients. Hepatology (Baltimore, Md.), 2006, Volume: 43, Issue:3 Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome	2006
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy. Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:2 Topics: Adenine; Adult; Disease Progression; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Virus Replication	2006
Hepatitis delta virus super-infection in a co-infected patient with the human immunodeficiency virus type 1 and a surface antigen-negative hepatitis B virus variant. International journal of STD & AIDS, 2006, Volume: 17, Issue:9 Topics: Adenine; Alanine Transaminase; Amino Acid Sequence; Anti-HIV Agents; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Hepatitis D; HIV Infections; HIV-1; Homosexuality, Male; Humans; Male; Middle Aged; Molecular Sequence Data; Organophosphonates; RNA, Viral; Superinfection; Tenofovir; Time Factors; Viral Load	2006
Aminotransferase elevation in HIV/hepatitis B virus co-infected patients treated with two active hepatitis B virus drugs. AIDS patient care and STDs, 2006, Volume: 20, Issue:12 Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; DNA, Viral; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Transaminases	2006
Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:3 Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Humans; Kidney Diseases; Lamivudine; Liver Transplantation; Organophosphonates; Secondary Prevention; Tenofovir	2007
Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'. AIDS (London, England), 2007, Mar-30, Volume: 21, Issue:6 Topics: Adenine; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure	2007
Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir. Antiviral therapy, 2007, Volume: 12, Issue:1 Topics: Adenine; CD4 Lymphocyte Count; DNA, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Liver Cirrhosis; Liver Failure; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Severity of Illness Index; Tenofovir; Time Factors; Treatment Outcome; Viral Load	2007
Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. Journal of medical virology, 2007, Volume: 79, Issue:10 Topics: Adenine; Adult; Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biomarkers; Carrier State; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; London; Male; Organophosphonates; Prevalence; Tenofovir	2007
Development of a novel mouse model to evaluate drug candidates against hepatitis B virus. Antiviral chemistry & chemotherapy, 2007, Volume: 18, Issue:4 Topics: Adenine; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Drug Evaluation, Preclinical; Hepatitis B; Hepatitis B virus; Lamivudine; Mice; Mice, Nude; Organophosphonates; Reproducibility of Results; Tenofovir	2007
Potency of tenofovir in chronic hepatitis B: mono or combination therapy? Journal of hepatology, 2008, Volume: 48, Issue:3 Topics: Adenine; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load	2008